syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.5616091	100.0
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	96.05476812346956
CRANIOSYNOSTOSIS 4; CRS4	1.5	96.05476812346956
SPEECH-LANGUAGE DISORDER 1	1.5	96.05476812346956
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	83.60322695353145
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	1.166894951	74.72388262850158
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	1.094561972	70.09193094481839
ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6	1.0909091	69.85801376285524
Lymphatic malformation 1	1.0666667	68.30561502235099
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.032288372	66.10414680600925
RETT SYNDROME; RTT	1.0173091909999998	65.1449323009196
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	1.0119047509999999	64.79885081356146
COFFIN-SIRIS SYNDROME 2; CSS2	1.0028732230000001	64.22050326166773
TEMPLE-BARAITSER SYNDROME; TMBTS	1.0028732230000001	64.22050326166773
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.00280899	64.21639000438714
MARTSOLF SYNDROME	1.0	64.03651208231305
BUTYRYLCHOLINESTERASE	1.0	64.03651208231305
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	1.0	64.03651208231305
CURVED NAIL OF FOURTH TOE	1.0	64.03651208231305
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484126	60.73303491891793
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.799107372	51.17204888214343
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	40.91219755315206
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.562538202	36.022984369135656
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.559113621	35.803686146552295
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	34.43704202287243
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.520825372	33.351840226853184
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.51998149	33.29780096696414
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	32.95997058418781
COFFIN-SIRIS SYNDROME 7; CSS7	0.512255032	32.803025545893654
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.510989	32.72195327242906
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.503724741	32.2567754632065
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.50280899	32.19813396323062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.50210084	32.15278650719953
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.502029341	32.14820796062215
COMBINED SAPOSIN DEFICIENCY	0.50111359	32.08956646064626
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.500843882	32.072295301045564
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.500843882	32.072295301045564
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	32.072295301045564
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.500369672	32.041928546651015
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.018256041156526
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.5	32.018256041156526
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.5	32.018256041156526
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.018256041156526
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.5	32.018256041156526
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	0.5	32.018256041156526
SPASTIC PARAPLEGIA 16, X-LINKED	0.5	32.018256041156526
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.018256041156526
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.493224663	31.584387091494275
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.48980467200000005	31.36538279650138
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.47881909	30.661904442027136
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	29.864637699665042
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.465200302	29.789804759718674
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.4484126	28.714778877761404
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.4484126	28.714778877761404
CENTRALOPATHIC EPILEPSY	0.4484126	28.714778877761404
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.4313729	27.623615922832418
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.43043879	27.563798776531208
DYSTONIA 6, TORSION	0.42326349	27.104317591386984
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.41778059	26.75321179929087
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	24.492601893777387
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	24.492601893777387
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.38033752000000004	24.35548819483698
EPILEPSY, JUVENILE ABSENCE	0.3752738	24.031225227875527
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.031225227875527
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.36265820000000004	23.223366206049903
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	23.21764018921252
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	23.13969609936315
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	23.030654726589386
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.354158372	22.67906686763032
LANDAU-KLEFFNER SYNDROME	0.351759633	22.525459988674502
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	22.40009244310884
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	22.287197224964938
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.343436142	21.992452656685977
AICARDI SYNDROME; AIC	0.33877179	21.693763823481817
CHROMOSOME 9P DELETION SYNDROME	0.337391312	21.60536282735545
HYPERTRYPTOPHANEMIA; HYPTRP	0.334176882	21.399521941822698
SECKEL SYNDROME 2; SCKL2	0.333333	21.345482681933653
STUTTERING, FAMILIAL PERSISTENT, 1; STUT1	0.333333	21.345482681933653
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	21.345482681933653
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	21.345482681933653
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.330749782	21.180062411265403
TUBEROUS SCLEROSIS	0.32591575100000003	20.87050792672763
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.3240339	20.750000752429017
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.317208182	20.312905579251556
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.30836459	19.746592793292507
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.285157582	18.260496945106173
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.27220304100000003	17.430933323838854
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.267582472	17.13504820124319
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.2613601	16.736589201484545
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.25995635300000003	16.646698139758538
CHARGE SYNDROME	0.25925926	16.60205873544154
HYPEREKPLEXIA 1; HKPX1	0.25925926	16.60205873544154
MICROPHTHALMIA, SYNDROMIC 1	0.254130181	16.2736104060869
POTOCKI-LUPSKI SYNDROME	0.253926943	16.260595753444314
KUFOR-RAKEB SYNDROME	0.25372474100000003	16.24764744262825
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.253016591	16.202299986597158
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.252944722	16.197697746510315
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.252944722	16.197697746510315
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.25280899	16.189005942652358
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.25280899	16.189005942652358
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.25280899	16.189005942652358
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.251957472	16.13447769995705
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.250843882	16.063167280467308
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	16.009128020578263
DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH	0.25	16.009128020578263
PRIMARY LATERAL SCLEROSIS, ADULT	0.25	16.009128020578263
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.25	16.009128020578263
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	16.009128020578263
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.25	16.009128020578263
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.009128020578263
HYPERPARATHYROIDISM 2	0.25	16.009128020578263
PHELAN-MCDERMID SYNDROME; PHMDS	0.23085004299999995	14.782831567771982
#615297 ADAMS-OLIVER SYNDROME 4; AOS4	0.22903935999999997	14.666881743965243
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.371592737260558
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.371592737260558
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.371592737260558
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.371592737260558
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.371592737260558
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.223770151	14.329459978172512
KAPUR-TORIELLO SYNDROME	0.222202311	14.22906097306938
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.210989	13.510999647735147
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.210989	13.510999647735147
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.20952369999999998	13.417166946580933
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.20952369999999998	13.417166946580933
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.20475654	13.111894647642613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.201957472	12.932652095841398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.201957472	12.932652095841398
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.2	12.80730241646261
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.19441408200000002	12.4495997109648
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.19426822299999996	12.440259409348982
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.19296020299999997	12.356498370815075
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	11.66382688215636
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.609787622267314
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.1805556	11.56215086092928
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.180240951	11.542001836439093
CHROMOSOME 16p13.2 DELETION SYNDROME	0.178477493	11.429076136915441
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.17464615100000003	11.18373035864097
COFFIN-SIRIS SYNDROME 5	0.17461696300000001	11.18186126092631
DYSTONIA 16; DYT16	0.17326349	11.095189570808724
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.172536012	11.048604417072108
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.16947599000000002	10.852651281296966
VELOCARDIOFACIAL SYNDROME	0.16808276	10.763433691568522
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.16778059	10.74408377871261
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.16778059	10.74408377871261
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.167582751	10.731414859198757
AMYOTROPHIC LATERAL SCLEROSIS 1	0.166667	10.67277335922287
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.166667	10.67277335922287
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.166667	10.67277335922287
SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE	0.166667	10.67277335922287
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.166667	10.67277335922287
DERMAL RIDGES, NELSON SYNDROME	0.166667	10.67277335922287
DERMATOGLYPHICS--FINGERPRINT PATTERN	0.166667	10.67277335922287
DERMATOGLYPHICS--PALMAR TRIRADIUS D, ABSENCE OF	0.166667	10.67277335922287
CRI-DU-CHAT SYNDROME	0.16414356	10.511181063173876
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.16170598099999997	10.35508700608878
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.15644237199999997	10.018023844763709
FOCAL DERMAL HYPOPLASIA; FDH	0.15421709999999997	9.875525187449275
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.152004953	9.733867009355926
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.150189441	9.617607953232342
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.146374782	9.373330496088938
CHROMOSOME 1P36 DELETION SYNDROME	0.146367503	9.37286437431749
KEIPERT SYNDROME; KPTS	0.14495783999999998	9.282594472585998
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.14495783999999998	9.282594472585998
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.14495783999999998	9.282594472585998
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.14319591299999998	9.169766812962346
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.14285699999999998	9.148064006542993
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.14285699999999998	9.148064006542993
#137580 GILLES DE LA TOURETTE SYNDROME; GTS;;TOURETTE SYNDROME; TS;;TOURETTE DISORDERCHRONIC MOTOR TICS, INCLUDED	0.14285699999999998	9.148064006542993
%614927 ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE; ECTD5	0.14285699999999998	9.148064006542993
%614149 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9;;ANONYCHIA-ONYCHOLYSIS, ISOLATED;;ONYCHODYSTROPHY;;NAIL DYSPLASIA	0.14285699999999998	9.148064006542993
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.14285699999999998	9.148064006542993
#172700 PICK DISEASE OF BRAIN;;LOBAR ATROPHY OF BRAIN;;DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS	0.14285699999999998	9.148064006542993
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.142310113	9.113043270559833
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.60807611840889
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	8.483473873199125
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.13198260199999998	8.451705487628113
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.13086901199999998	8.38039506813837
DYSTONIA 28, CHILDHOOD-ONSET	0.128652872	8.238481192252273
DUBOWITZ SYNDROME	0.12865255	8.238460572495383
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.127899951	8.190266757538748
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.12787322299999998	8.18855518964381
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.12787322299999998	8.18855518964381
DYSTONIA 26, MYOCLONIC; DYT26	0.12780899	8.184441932363228
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.125915751	8.06320551026502
FLYNN-AIRD SYNDROME	0.125915751	8.06320551026502
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	8.06320551026502
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	8.06320551026502
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.052200771627161
DYSTONIA 25	0.125	8.004564010289132
MASA SYNDROME	0.125	8.004564010289132
CREUTZFELDT-JAKOB DISEASE; CJD	0.125	8.004564010289132
DYSTONIA 27; DYT27	0.125	8.004564010289132
Polyarteritis nodosa, childhood-onset	0.125	8.004564010289132
DYSTONIA 21; DYT21	0.125	8.004564010289132
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.12250904000000001	7.845051620152573
WHITE-SUTTON SYNDROME; WHSUS	0.12045175200000001	7.713310072283774
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.11805560000000001	7.559868855784717
TONNE-KALSCHEUER SYNDROME; TOKAS	0.113585372	7.273611046452022
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.11142860000000002	7.135498890215228
SMITH-MAGENIS SYNDROME; SMS	0.11106994300000002	7.112531746901323
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.11091769	7.102781995827252
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.10878729	6.966358610487092
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.1066667	6.83056342333046
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.105259092	6.7404251166313
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.10405831200000001	6.663531353653101
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.10275864100000001	6.580304955958568
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.102351122	6.554208860591296
ADDUCTED THUMBS SYNDROME	0.10111359	6.474961627721047
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.10111359	6.474961627721047
ADAMS-OLIVER SYNDROME 5; AOS5	0.10108411100000002	6.473073895381373
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.10091575100000001	6.462292708207196
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.10091575100000001	6.462292708207196
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	6.462292708207196
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.10091575100000001	6.462292708207196
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.10038540200000001	6.428331008060853
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.403651208231305
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.1	6.403651208231305
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.403651208231305
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.403651208231305
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.1	6.403651208231305
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.403651208231305
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.403651208231305
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.1	6.403651208231305
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.403651208231305
PALATOPHARYNGEAL INCOMPETENCE	0.1	6.403651208231305
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.1	6.403651208231305
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.403651208231305
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.09903390000000001	6.341785533908582
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	6.188160788765895
PELIZAEUS-MERZBACHER DISEASE	0.09659131300000001	6.185370781970981
SPINOCEREBELLAR ATAXIA 1	0.09483168	6.072690022106044
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.09463384100000001	6.0600211025921915
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.09463384100000001	6.0600211025921915
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.09371809	6.001379602616301
ACERULOPLASMINEMIA	0.09371809	6.001379602616301
SPINOCEREBELLAR ATAXIA 15	0.09371809	6.001379602616301
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.09371809	6.001379602616301
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.09258567200000001	5.928863503677072
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.09254810000000001	5.926457523845116
FUMARASE DEFICIENCY; FMRD	0.092253972	5.9076225926193695
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.09162479	5.867331971874394
BOHRING-OPITZ SYNDROME	0.09133178300000001	5.848568825578694
BETA-UREIDOPROPIONASE DEFICIENCY	0.09114038200000002	5.8363121731296275
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.0909091	5.821501680542205
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.0909091	5.821501680542205
#607523 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8;;TOENAIL DYSTROPHY, ISOLATED	0.0909091	5.821501680542205
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS; EBSSH	0.0909091	5.821501680542205
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.0909091	5.821501680542205
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.0909091	5.821501680542205
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.0909091	5.821501680542205
Boucher-Neuhauser syndrome	0.0909091	5.821501680542205
COSTELLO SYNDROME; CSTLO	0.09001962200000001	5.7645426118482535
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.089731551	5.746095549776189
AU-KLINE SYNDROME; AUKS	0.088448792	5.663952137573993
MCDONOUGH SYNDROME	0.0879121	5.629584253831513
FONTAINE PROGEROID SYNDROME; FPS	0.08733711000000001	5.592763899749303
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.08712253	5.579022944986681
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.08705360000000001	5.574608908208847
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0862745	5.524718061645516
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.08486261300000002	5.434305742711157
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.083828872	5.368108574674673
BARDET-BIEDL SYNDROME 1; BBS1	0.08376678200000001	5.364132547639484
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.08187140000000001	5.242758895295885
TARP SYNDROME; TARPS	0.081714012	5.232680316732273
WEAVER SYNDROME	0.081608173	5.225902756329994
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.08093399	5.182730428504803
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0806818	5.1665810605227644
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.08040535	5.1488781667576085
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.07993969100000001	5.119058988577872
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.079867822	5.114456748491027
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.07978016200000002	5.108843307841893
MCLEOD SYNDROME; MCLDS	0.07973209	5.105764944633071
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07973209	5.105764944633071
ERYTHERMALGIA, PRIMARY	0.07969622	5.103467954944678
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.07902394000000001	5.060417488601981
FIBROCHONDROGENESIS 1; FBCG1	0.07902394000000001	5.060417488601981
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	5.0504892677687385
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.07862168200000001	5.034658289324775
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.07803669	4.9971974420487175
#278250 WRINKLY SKIN SYNDROME; WSS	0.07802680000000001	4.996564120944224
SMITH-KINGSMORE SYNDROME; SKS	0.077955301	4.99198557436685
LISSENCEPHALY 2; LIS2	0.07776698200000001	4.979926282448021
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.077472072	4.961041274669826
CANAVAN DISEASE	0.07692310000000001	4.9258870225589755
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.07692310000000001	4.9258870225589755
ADAMS-OLIVER SYNDROME 6; AOS6	0.07692310000000001	4.9258870225589755
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.07692310000000001	4.9258870225589755
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	4.9258870225589755
MYOCLONUS AND ATAXIA	0.07692310000000001	4.9258870225589755
MENTAL RETARDATION, X-LINKED 98; MRX98	0.075790183	4.853338969400216
LYMPHEDEMA, HEREDITARY, III	0.075707302	4.848031559242322
HALLERMANN-STREIFF SYNDROME; HSS	0.07563024	4.843096777548235
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.074910051	4.7969783859481865
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.765821356958025
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	4.765821356958025
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.07398959000000001	4.738035274000389
15q26 overgrowth syndrome	0.07352944000000002	4.708568872965713
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.073483771	4.705644389495425
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.07345794100000001	4.70399032638834
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.07338607200000001	4.699388086301496
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.072865713	4.666066110910854
SHASHI-PENA SYNDROME; SHAPNS	0.07164076300000001	4.587624585435625
AL KAISSI SYNDROME; ALKAS	0.07164076300000001	4.587624585435625
ALZHEIMER DISEASE 10	0.07142860000000001	4.574038406922706
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.07142860000000001	4.574038406922706
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.07142860000000001	4.574038406922706
HISTIDINEMIA	0.07142860000000001	4.574038406922706
NOONAN SYNDROME 7; NS7	0.070796881	4.533585325546579
CORNELIA DE LANGE SYNDROME 3	0.07038335300000001	4.5071044347782045
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	4.499301393671438
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	4.499301393671438
THROMBOCYTOPENIA 1	0.069873	4.474423208727459
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.06914097200000001	4.427546688860868
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.06914097200000001	4.427546688860868
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.068426333	4.3817836999028765
Pierpont syndrome	0.068426333	4.3817836999028765
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.068182213	4.366151106573342
NIEMANN-PICK DISEASE, TYPE C2	0.068182213	4.366151106573342
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.068182213	4.366151106573342
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.068182213	4.366151106573342
COWDEN SYNDROME 5; CWS5	0.067582451	4.327744440013829
COWDEN SYNDROME 6; CWS6	0.067582451	4.327744440013829
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.067510582	4.323142199926985
METACHROMATIC LEUKODYSTROPHY	0.067338331	4.312111846684295
PEROXISOME BIOGENESIS DISORDER 14B	0.0666667	4.269102940037939
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.0666667	4.269102940037939
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.0666667	4.269102940037939
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.0666667	4.269102940037939
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.06620555100000002	4.239572566527693
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.06537322300000001	4.186273184499245
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.06537322300000001	4.186273184499245
GM2-GANGLIOSIDOSIS, AB VARIANT	0.06537322300000001	4.186273184499245
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.108774724737452
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0641259	4.106398970139198
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.063415751	4.0609235051204555
Adrenoleukodystrophy	0.063415751	4.0609235051204555
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.063415751	4.0609235051204555
AICARDI-GOUTIERES SYNDROME 6	0.063343882	4.056321265033612
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	4.049918766482597
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	4.049918766482597
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0626959	4.01482675786149
EPISODIC ATAXIA, TYPE 1; EA1	0.06163249	3.946729690548038
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.06163249	3.946729690548038
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.06092434	3.901382234516948
WIDOW&#39;S PEAK SYNDROME	0.06092434	3.901382234516948
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.060788413	3.8926779435391348
RETT SYNDROME, CONGENITAL VARIANT	0.060787491	3.8926189018749953
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.060393931	3.86741669217988
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.060124223	3.8501455325791833
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.8351210940048954
Fabry disease	0.059739251	3.825493268449832
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.059686071	3.822087806737294
ALSTROM SYNDROME; ALMS	0.059667382	3.8208910283629876
MUCOLIPIDOSIS III GAMMA	0.0588235	3.766851768473941
245800 LAURENCE-MOON SYNDROME	0.0588235	3.766851768473941
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0588235	3.766851768473941
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0588235	3.766851768473941
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0588235	3.766851768473941
DERMOCHONDROCORNEAL DYSTROPHY	0.0588235	3.766851768473941
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0588235	3.766851768473941
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.0588235	3.766851768473941
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.058542322	3.748846110079661
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.05836459	3.737464772714247
DYSTONIA 12; DYT12	0.05836459	3.737464772714247
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.05836459	3.737464772714247
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.058184200000000005	3.7259132262997188
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.05817322099999999	3.725210169433566
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.627457088973162
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.056520413	3.6193701099718227
RICHARDS-RUNDLE SYNDROME; RRNS	0.056399482	3.6116261105291967
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.557586850640151
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	3.557586850640151
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.557586850640151
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.557586850640151
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.557586850640151
CHROMOSOME 17q12 DELETION SYNDROME	0.055555600000000004	3.557586850640151
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.055555600000000004	3.557586850640151
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.055295731	3.5409457462818317
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.054496792999999995	3.4897845433918127
HYDROXYKYNURENINURIA	0.053475482	3.424383349200513
NETHERTON SYNDROME; NETH	0.053475482	3.424383349200513
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.053475482	3.424383349200513
#227600 FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY	0.0526316	3.3703440893114673
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0526316	3.3703440893114673
ROWLEY-ROSENBERG SYNDROME	0.0526316	3.3703440893114673
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0526316	3.3703440893114673
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0526316	3.3703440893114673
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.0526316	3.3703440893114673
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0526316	3.3703440893114673
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0526316	3.3703440893114673
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0526316	3.3703440893114673
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0526316	3.3703440893114673
CRAMPS, FAMILIAL ADOLESCENT	0.0526316	3.3703440893114673
JOHANSON-BLIZZARD SYNDROME; JBS	0.05210259	3.336468134054803
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.051376653	3.289981660583305
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.051321689999999996	3.286462021769724
EPILEPSY, PYRIDOXINE-DEPENDENT	0.051156272	3.2758692300140924
ROIFMAN SYNDROME; RFMN	0.050596072	3.2399959759455803
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	3.2208849833162474
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.050023122999999996	3.203306320384531
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.04943728299999999	3.1657911701462287
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.04925926	3.1543911981557997
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.1082042234513105
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	3.1082042234513105
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.04826349	3.0906255605195945
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.04826349	3.0906255605195945
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.04826349	3.0906255605195945
SPINOCEREBELLAR ATAXIA 20	0.04826349	3.0906255605195945
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.04826349	3.0906255605195945
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.047203041	3.022718105318418
ALZHEIMER DISEASE 3; AD	0.047203041	3.022718105318418
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.047131172	3.018115865231574
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.04656809	2.9820580579352414
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.04628729	2.9640766053425276
MAST SYNDROME	0.04628729	2.9640766053425276
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.04628729	2.9640766053425276
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.04628729	2.9640766053425276
DYSTONIA 23; DYT23	0.0454545	2.910747638445498
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.0454545	2.910747638445498
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.0454545	2.910747638445498
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0454545	2.910747638445498
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.0454545	2.910747638445498
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.0454545	2.910747638445498
DYSTONIA 7, TORSION	0.0454545	2.910747638445498
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.0454545	2.910747638445498
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0454545	2.910747638445498
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.045274652	2.8992307998205185
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.044811001999999996	2.8695402709935536
COFFIN-SIRIS SYNDROME 6; CSS6	0.04466671199999999	2.860300442665196
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.04459189	2.8555091027581745
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.04383069	2.8067645097611176
ALZHEIMER DISEASE 4	0.043478300000000004	2.784198683268431
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.042979172	2.7522362670658107
MOEBIUS SYNDROME; MBS	0.04280899	2.7413384053666183
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.042784682000000004	2.739781805830922
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.04246714299999999	2.7194477158208152
OTOONYCHOPERONEAL SYNDROME	0.04210084	2.695990949335528
SCALP-EAR-NIPPLE SYNDROME; SENS	0.04210084	2.695990949335528
PELGER-HUET ANOMALY; PHA	0.04205044199999999	2.692763637199603
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.6809258475760673
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.041596572	2.663699385460804
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.041566991	2.6618051213968976
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.04116176	2.6358555415692693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.04081692299999999	2.6137733828523406
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.04065124	2.603163621421007
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.04055640199999999	2.5970905266881443
TURNPENNY-FRY SYNDROME; TPFS	0.04026623199999999	2.5785090519772194
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.04	2.561460483292522
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.04	2.561460483292522
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.04	2.561460483292522
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.04	2.561460483292522
TOE, ROTATED FIFTH	0.04	2.561460483292522
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.04	2.561460483292522
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.04	2.561460483292522
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.04	2.561460483292522
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.04	2.561460483292522
NASODIGITOACOUSTIC SYNDROME	0.04	2.561460483292522
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.04	2.561460483292522
NAIL HIGH-SULFUR PROTEIN	0.04	2.561460483292522
NAIL LOW-SULFUR PROTEIN	0.04	2.561460483292522
CHILBLAIN LUPUS 1	0.04	2.561460483292522
NAILBEDS, PIGMENTATION OF	0.04	2.561460483292522
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.04	2.561460483292522
ADACTYLIA, UNILATERAL	0.04	2.561460483292522
LUNULAE OF FINGERNAILS	0.04	2.561460483292522
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.03948658299999999	2.528583049368756
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.03900717199999999	2.4978832410748626
THUMBS, CONGENITAL CLASPED	0.0384757	2.4638496279254523
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0379437	2.4297822034976613
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.03738574299999999	2.3940525833257498
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.3647467218268643
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.3647467218268643
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.036794822	2.3562120635695574
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.03646999199999999	2.3354110833498596
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.036199912	2.3181161021666687
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.035870833	2.2970430308071332
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.03552093	2.274636463119996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.035201403	2.2541750685238706
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.03481020099999999	2.229123856924245
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.034810180999999996	2.229122576194004
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.034641522999999994	2.2183223061392248
YUNIS-VARON SYNDROME	0.03461163	2.216408062683548
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.034576161999999994	2.2141368156730126
RING CHROMOSOME 14 SYNDROME	0.034554112	2.212724810581598
PITT-HOPKINS SYNDROME	0.034436911	2.2052196673290387
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	2.203988309238208
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.034214153	2.190955021970607
CORNELIA DE LANGE SYNDROME 1	0.033696611	2.157813437434503
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.1499490493491615
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.03354533	2.148125929850178
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.03354533	2.148125929850178
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.03307855299999999	2.1182351588499317
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.033060889999999996	2.117104081937022
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.03266323199999999	2.0916394506153937
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.032465392999999995	2.078970531101541
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.032453272	2.0781943445385913
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.03238146	2.0735957545329367
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.032319401	2.0696217126296204
CIRCUMVALLATE PLACENTA SYNDROME	0.032266	2.0662020988479126
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.031881812999999995	2.041600103380545
KOOLEN-DE VRIES SYNDROME; KDVS	0.031742523	2.0326804576126
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0315261	2.0188214835582095
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.031318203	2.0055084848058327
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.031289863	2.00369369005342
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.030894563	1.9783800568272816
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.030886353	1.9778543170630856
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.030653582	1.9629484741091736
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.030626693	1.9612265963357922
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.030519981999999998	1.9543931960949765
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.030364553	1.9444400650585347
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.030364553	1.9444400650585347
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.9422850443174287
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.9422850443174287
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.030176273	1.9323832705636768
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.029899600000000002	1.914666096656327
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.029513173	1.8899206594018951
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.029260522	1.8737417705877866
RAINE SYNDROME	0.029260522	1.8737417705877866
KLEEFSTRA SYNDROME 2; KLEFS2	0.029189023	1.8691632240104135
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.029189023	1.8691632240104135
IMMUNODEFICIENCY 49; IMD49	0.028651913	1.8347685730058823
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.02860492	1.831759305193598
CHROMOSOME 3q13.31 DELETION SYNDROME	0.02841664	1.8197025106987401
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.02841664	1.8197025106987401
ZUNICH NEUROECTODERMAL SYNDROME	0.028345141	1.8151239641213668
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.028345141	1.8151239641213668
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.028306552999999998	1.8126529231931345
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.028273272000000002	1.8105217240345233
CRANIOSYNOSTOSIS 6; CRS6	0.028273272000000002	1.8105217240345233
MENTAL RETARDATION, X-LINKED 41	0.028273272000000002	1.8105217240345233
HAREL-YOON SYNDROME; HAYOS	0.028273272000000002	1.8105217240345233
Muenke syndrome	0.028075433	1.7978528045206703
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.02742528	1.7562192740808182
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.027344542000000003	1.7510490941683166
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.027231551	1.7438135446316239
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.027197753	1.741649238596266
PROPIONIC ACIDEMIA	0.027197753	1.741649238596266
Temtamy preaxial brachydactyly syndrome	0.027159682	1.7392113045447803
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.026807222000000002	1.716640995496248
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.026766441999999998	1.714029586533531
WILLIAMS-BEUREN SYNDROME; WBS	0.02676629	1.7140198529836947
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.026475783	1.695416797968198
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.026396711	1.6903533028848257
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.0263158	1.6851720446557337
FACIOCARDIORENAL SYNDROME	0.0263158	1.6851720446557337
ROBINOW-SORAUF SYNDROME	0.0263158	1.6851720446557337
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.6851720446557337
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.0263158	1.6851720446557337
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.6851720446557337
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0263158	1.6851720446557337
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.026181841	1.676593777533699
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.026080153	1.6700820326930728
Pontine tegmental cap dysplasia	0.026080153	1.6700820326930728
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.026080153	1.6700820326930728
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.025875072000000002	1.65694936075872
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.025850502	1.6553759836568576
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.025850502	1.6553759836568576
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.025850502	1.6553759836568576
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025850502	1.6553759836568576
ROIFMAN-CHITAYAT SYNDROME	0.025728142	1.6475404760384658
SCHAAF-YANG SYNDROME; SHFYNG	0.025279042999999998	1.6187817424988107
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.025166922	1.61160190472763
LATERAL MENINGOCELE SYNDROME	0.02513189	1.6093585776363624
CURRY-JONES SYNDROME	0.024996382	1.6006811179571125
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.024736912	1.5840655641671146
Congenital disorder of glycosylation, type IIh	0.024736912	1.5840655641671146
PEHO-LIKE SYNDROME; PEHOL	0.024736912	1.5840655641671146
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.024550113000000002	1.5721036077466506
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.024497492	1.568733942444367
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.024435160999999997	1.5647424826097642
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.02432304	1.5575626448385833
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.024306572	1.5565080915576117
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.024291793	1.5555616959455474
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.024291793	1.5555616959455474
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.024251541	1.5529840982612102
COFFIN-SIRIS SYNDROME 1; CSS1	0.024108733	1.543839172043759
PETERS-PLUS SYNDROME; PTRPLS	0.024108733	1.543839172043759
CATEL-MANZKE SYNDROME; CATMANS	0.024108733	1.543839172043759
#614970 JOUBERT SYNDROME 20; JBTS20	0.024050811999999998	1.5401301132274394
ALAZAMI-YUAN SYNDROME	0.023966082	1.534704299558705
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02389303	1.530026304278068
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.02389303	1.530026304278068
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.023447911	1.5015224360565007
GAUCHER DISEASE, PERINATAL LETHAL	0.023424790999999997	1.5000419118971577
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.023376042	1.496920195969657
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.023376042	1.496920195969657
TYSHCHENKO SYNDROME	0.023352921999999998	1.495439671810314
EPILEPSY, HOT WATER, 1	0.023335790000000002	1.49434259828532
KAGAMI-OGATA SYNDROME	0.023281423	1.4908611252329407
INFANTILE SIALIC ACID STORAGE DISEASE	0.023281423	1.4908611252329407
Xq28 (MECP2) duplication	0.023178202999999998	1.4842512764558042
WIEACKER-WOLFF SYNDROME	0.023155863	1.4828207007758853
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.4770714386846235
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.4770714386846235
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.023062903	1.4768678666127137
JOUBERT SYNDROME 32; JBTS32	0.022948262	1.4695266568310854
PEROXISOME BIOGENESIS DISORDER 5B	0.022948262	1.4695266568310854
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.022926212	1.4681146517396704
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.022854399999999997	1.4635160617340148
ZIMMERMANN-LABAND SYNDROME 1	0.022782900999999998	1.4589375151566417
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.022750423	1.4568577373172324
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.022697843000000002	1.4534906975119448
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.022614553	1.4481570964206085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.022607602	1.4477119786251245
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.022607602	1.4477119786251245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.022607602	1.4477119786251245
DESANTO-SHINAWI SYNDROME	0.022564242999999998	1.4449354194977473
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.022564242999999998	1.4449354194977473
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.022520772	1.4421516882810173
KNIEST-LIKE DYSPLASIA, LETHAL	0.022509039999999998	1.4414004119212673
RESTRICTIVE DERMOPATHY, LETHAL	0.022509039999999998	1.4414004119212673
LICHTENSTEIN SYNDROME	0.022483299999999998	1.4397521121002688
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.022416790000000002	1.4354930436816742
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.022365672	1.4322196252570505
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.022365672	1.4322196252570505
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.022365671999999996	1.4322196252570503
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.022345010999999998	1.4308965668809177
PALLISTER-KILLIAN SYNDROME	0.022277601	1.4265798656014492
JOUBERT SYNDROME 35; JBTS35	0.022240112	1.4241792007999954
JOUBERT SYNDROME 1	0.022240112	1.4241792007999954
OROFACIODIGITAL SYNDROME XVI; OFD16	0.022240112	1.4241792007999954
JOUBERT SYNDROME 2	0.022240112	1.4241792007999954
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4230321787955769
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.4230321787955769
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4230321787955769
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	1.4230321787955769
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.4230321787955769
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.4230321787955769
BRANCHIOOCULOFACIAL SYNDROME	0.022202311	1.4217585566067716
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.022167832999999998	1.4195507057431975
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.022167832999999998	1.4195507057431975
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.022167832999999998	1.4195507057431975
SPINOCEREBELLAR ATAXIA 2; SCA2	0.02210438	1.4154873969420387
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.022058943	1.4125777699425548
IMMUNODEFICIENCY 23; IMD23	0.022007862000000003	1.4093067208688783
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.021810023	1.3966378013550254
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.021791859999999996	1.395474706186074
HYPERPROLINEMIA, TYPE I	0.021741123	1.3922256856725541
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.02167689	1.3881124283919708
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.021669310999999997	1.3876270956668986
HURLER SYNDROME	0.021597441999999998	1.383024855580055
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.02152179	1.378180365368004
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02152179	1.378180365368004
NEMALINE MYOPATHY 10	0.02152179	1.378180365368004
TEMPLE SYNDROME	0.02152179	1.378180365368004
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02152179	1.378180365368004
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.02152179	1.378180365368004
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.021494012	1.3764015591353813
JOUBERT SYNDROME 3; JBTS3	0.02139623	1.3701399409109487
EMANUEL SYNDROME	0.021367503	1.3683003640283602
BAND HETEROTOPIA; BH	0.021367433	1.3682958814725146
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	1.365511445854151
KLEEFSTRA SYNDROME	0.021215061	1.3585385100535081
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.021055023	1.348290234732879
COACH SYNDROME	0.021055023	1.348290234732879
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.021055023	1.348290234732879
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.02099079	1.3441769774522958
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.02099079	1.3441769774522958
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.02099079	1.3441769774522958
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.02099079	1.3441769774522958
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.02099079	1.3441769774522958
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.02099079	1.3441769774522958
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02096874	1.3427649723608808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.020825372	1.3335841856966637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.020825372	1.3335841856966637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.020825372	1.3335841856966637
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.020753559999999997	1.3289855956910084
Lipodystrophy, congenital generalized, type 2	0.020753559999999997	1.3289855956910084
Lipodystrophy, congenital generalized, type 1	0.020753559999999997	1.3289855956910084
HURLER-SCHEIE SYNDROME	0.020753559999999997	1.3289855956910084
FLOATING-HARBOR SYNDROME	0.020753559999999997	1.3289855956910084
COPPER DEFICIENCY, FAMILIAL BENIGN	0.020523551	1.314256621583468
HHHH SYNDROME	0.020523551	1.314256621583468
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.020523551	1.314256621583468
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.02045583	1.3099200049487416
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.020451752	1.3096588640524698
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.3068699458782609
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.3068699458782609
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.3068699458782609
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.3068699458782609
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	1.3068699458782609
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	1.3068699458782609
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.3068699458782609
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.3068699458782609
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	1.3068699458782609
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.3068699458782609
Diamond-Blackfan anemia 1	0.020408199999999998	1.3068699458782609
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	1.3068699458782609
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.3068699458782609
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	1.3068699458782609
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.3068699458782609
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.020257991	1.2972510854348889
611961 STEVENSON-CAREY SYNDROME	0.020253913	1.296989944538617
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.020253913	1.296989944538617
MACS SYNDROME	0.02024826	1.296627946135816
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.020186122	1.2926488453480451
JOUBERT SYNDROME 21	0.020139272	1.2896487347569887
JOUBERT SYNDROME 25	0.020139272	1.2896487347569887
JOUBERT SYNDROME 27	0.020139272	1.2896487347569887
JOUBERT SYNDROME 15	0.020139272	1.2896487347569887
JOUBERT SYNDROME 28	0.020139272	1.2896487347569887
JOUBERT SYNDROME 8	0.020139272	1.2896487347569887
JOUBERT SYNDROME 6	0.020139272	1.2896487347569887
JOUBERT SYNDROME 7	0.020139272	1.2896487347569887
JOUBERT SYNDROME 31; JBTS31	0.020139272	1.2896487347569887
SULFOCYSTEINURIA	0.020114622999999998	1.2880702987706718
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.01998149	1.2795449258076175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01998149	1.2795449258076175
GAUCHER DISEASE, TYPE II	0.019941432999999998	1.2769798152431358
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	1.2622737662069208
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	1.2622737662069208
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.019711782	1.2622737662069208
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.019711782	1.2622737662069208
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.019711782	1.2622737662069208
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.019691019999999997	1.2609442401430675
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	1.2556151216075777
PUBIC BONE DYSPLASIA	0.0196078	1.2556151216075777
TRACHEOBRONCHOMEGALY	0.0196078	1.2556151216075777
TOE, MISSHAPEN	0.0196078	1.2556151216075777
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	1.2556151216075777
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	1.2556151216075777
THROMBOCYTOPENIA 3	0.0196078	1.2556151216075777
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	1.2556151216075777
THALIDOMIDE SUSCEPTIBILITY	0.0196078	1.2556151216075777
VAN DEN BOSCH SYNDROME	0.0196078	1.2556151216075777
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	1.2556151216075777
NEPHROSIALIDOSIS	0.0196078	1.2556151216075777
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	1.2556151216075777
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	1.2556151216075777
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	1.2556151216075777
MONOPHALANGY OF GREAT TOE	0.0196078	1.2556151216075777
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	1.2556151216075777
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	1.2556151216075777
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	1.2556151216075777
MEGAEPIPHYSEAL DWARFISM	0.0196078	1.2556151216075777
CARPAL DISPLACEMENT	0.0196078	1.2556151216075777
#215300 CHONDROSARCOMA	0.0196078	1.2556151216075777
DOUBLE NAIL FOR FIFTH TOE	0.0196078	1.2556151216075777
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	1.2556151216075777
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	1.2556151216075777
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	1.2556151216075777
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	1.2556151216075777
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	1.2556151216075777
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	1.2556151216075777
SPINAL ARACHNOIDITIS	0.0196078	1.2556151216075777
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	1.2556151216075777
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	1.2556151216075777
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	1.2556151216075777
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	1.2556151216075777
KNUCKLE PADS	0.0196078	1.2556151216075777
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	1.2556151216075777
PACHYDERMODACTYLY, FAMILIAL	0.0196078	1.2556151216075777
RAYNAUD DISEASE	0.0196078	1.2556151216075777
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	1.2556151216075777
VESICOURETERAL REFLUX 1	0.0196078	1.2556151216075777
LETTERER-SIWE DISEASE	0.0196078	1.2556151216075777
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.019464152	1.2464164047199775
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.019413452	1.2431697535574044
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.019413452	1.2431697535574044
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.019413452	1.2431697535574044
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.019410030999999998	1.2429506846495706
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.01929539	1.2356094748679423
JOUBERT SYNDROME 5	0.01929539	1.2356094748679423
JOUBERT SYNDROME 4	0.01929539	1.2356094748679423
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.019277872	1.2344876832492844
COFFIN-SIRIS SYNDROME 8; CSS8	0.019270741	1.2340310388816254
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.019266663	1.2337698979853535
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.019198872	1.2294287987947814
JOUBERT SYNDROME 33; JBTS33	0.019025682	1.2183383152672458
JOUBERT SYNDROME 17; JBTS17	0.019025682	1.2183383152672458
MECKEL SYNDROME 13; MKS13	0.019025682	1.2183383152672458
CHROMOSOME 2q37 DELETION SYNDROME	0.019001033	1.2167598792809289
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.019001033	1.2167598792809289
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.018887353000000003	1.2094802085874117
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.2082345063178743
MOTION SICKNESS	0.0188679	1.2082345063178743
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.2082345063178743
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.2082345063178743
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.2082345063178743
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.2082345063178743
JUMPING FRENCHMAN OF MAINE	0.0188679	1.2082345063178743
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.2082345063178743
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.2082345063178743
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.2082345063178743
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.2082345063178743
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.2082345063178743
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.2082345063178743
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.2082345063178743
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.2082345063178743
PALMOMENTAL REFLEX	0.0188679	1.2082345063178743
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.2082345063178743
DIASTEMATOMYELIA	0.0188679	1.2082345063178743
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.2082345063178743
MYOPATHY, CONGENITAL	0.0188679	1.2082345063178743
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.2082345063178743
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.2082345063178743
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.2082345063178743
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	1.2082345063178743
CARDIAC ARRHYTHMIA	0.0188679	1.2082345063178743
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.2082345063178743
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.2082345063178743
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.2082345063178743
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.2082345063178743
TRANSSEXUALITY	0.0188679	1.2082345063178743
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.2082345063178743
CERVICAL RIB	0.0188679	1.2082345063178743
RHEUMATOID ARTHRITIS	0.0188679	1.2082345063178743
ALCOHOL DEPENDENCE	0.0188679	1.2082345063178743
269800 SENILE PLAQUE FORMATION	0.0188679	1.2082345063178743
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.2082345063178743
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.2082345063178743
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.2082345063178743
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.2082345063178743
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.2082345063178743
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.2082345063178743
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.2082345063178743
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.2082345063178743
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.2082345063178743
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	1.2082345063178743
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.2082345063178743
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.2082345063178743
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.2082345063178743
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.2082345063178743
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.2082345063178743
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.2082345063178743
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	1.2082345063178743
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.01856957	1.1891304936683578
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.01856957	1.1891304936683578
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.018498223	1.184561680640821
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01843399	1.1804484233602377
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.018412663	1.179082716667058
MENTAL RETARDATION, X-LINKED 101; MRX101	0.018412663	1.179082716667058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.018350911999999997	1.1751283980094631
TOWNES-BROCKS SYNDROME 1; TBS1	0.018299862	1.1718593340676613
OCULAR MOTOR APRAXIA	0.018181799999999998	1.164299055378199
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.018181799999999998	1.164299055378199
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.018181799999999998	1.164299055378199
#614465 JOUBERT SYNDROME 16; JBTS16	0.018181799999999998	1.164299055378199
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.018181799999999998	1.164299055378199
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.018181799999999998	1.164299055378199
PHENYLKETONURIA	0.018157151	1.1627206193918822
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.018157151	1.1627206193918822
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.018157151	1.1627206193918822
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.018085282	1.1581183793050387
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.017582472000000002	1.1259201806649308
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.01750703	1.1210891381204169
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.01750703	1.1210891381204169
MEIER-GORLIN SYNDROME 6; MGORS6	0.01745598	1.1178200741786148
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.01745598	1.1178200741786148
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.01745598	1.1178200741786148
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.017435180999999998	1.1164881787638146
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.017310113000000002	1.108479260270704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.017310113000000002	1.108479260270704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.017280162	1.1065613026973267
MYCOSIS FUNGOIDES	0.0172414	1.104079119415992
IMMUNODEFICIENCY 50; IMD50	0.0172414	1.104079119415992
DERMATITIS, ATOPIC	0.0172414	1.104079119415992
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0172414	1.104079119415992
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.0172414	1.104079119415992
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.0172414	1.104079119415992
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.0172414	1.104079119415992
PORPHYRIA CUTANEA TARDA, TYPE I	0.0172414	1.104079119415992
CASPASE 8 DEFICIENCY	0.0172414	1.104079119415992
BAZEX SYNDROME; BZX	0.0172414	1.104079119415992
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0172414	1.104079119415992
BLAU SYNDROME	0.0172414	1.104079119415992
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.0172414	1.104079119415992
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0172414	1.104079119415992
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.0172414	1.104079119415992
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.0172414	1.104079119415992
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0172414	1.104079119415992
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0172414	1.104079119415992
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.0172414	1.104079119415992
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.0172414	1.104079119415992
#615607 IMMUNODEFICIENCY 17; IMD17;;CD3-GAMMA DEFICIENCY;;SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE	0.0172414	1.104079119415992
IMMUNODEFICIENCY 55; IMD55	0.0172414	1.104079119415992
NEUTROPHIL CHEMOTACTIC RESPONSE	0.0172414	1.104079119415992
IGE RESPONSIVENESS, ATOPIC	0.0172414	1.104079119415992
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.0172414	1.104079119415992
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.0172414	1.104079119415992
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.0172414	1.104079119415992
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.0172414	1.104079119415992
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.017237322	1.1038179785197202
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.017237322	1.1038179785197202
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.016788381	1.075069362748975
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.016788381	1.075069362748975
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.016663372	1.0670642224100768
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.016601963	1.063131804239614
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	1.0592120012620314
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.0592120012620314
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	1.0546097611751877
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	1.0546097611751877
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	1.0546097611751877
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.016468882	1.0546097611751877
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	1.0546097611751877
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	1.0546097611751877
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	1.0546097611751877
#300867 KABUKI SYNDROME 2; KABUK2	0.016468362999999996	1.0545765262254168
WAISMAN SYNDROME; WSMN	0.016196523	1.0371688407809612
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.016196523	1.0371688407809612
ANGELMAN SYNDROME	0.016095072999999998	1.0306723366302104
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.016095072999999998	1.0306723366302104
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.015979772999999996	1.0232889267871195
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.015963063	1.0222188766702243
ADAMS-OLIVER SYNDROME 2; AOS2	0.015963063	1.0222188766702243
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.015872630000000002	1.0164278627730845
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.015758081	1.0090925443505676
PAINE SYNDROME	0.015625	1.0005705012861414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.015625	1.0005705012861414
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.0005705012861414
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	1.0005705012861414
CARNOSINEMIA	0.015625	1.0005705012861414
HYDROXYLYSINURIA	0.015625	1.0005705012861414
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	1.0005705012861414
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.015625	1.0005705012861414
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.0005705012861414
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	1.0005705012861414
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.0005705012861414
MICROHYDRANENCEPHALY; MHAC	0.015625	1.0005705012861414
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	1.0003560430071774
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.0003560430071774
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.015552611999999999	0.9959350262495268
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	0.9957538029203338
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.015549782	0.9957538029203338
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	0.9957538029203338
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.015549782	0.9957538029203338
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.015488373	0.991821384749871
SPINOCEREBELLAR ATAXIA 34; SCA34	0.015467190000000002	0.9904648993144315
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.015352641	0.9831295808919146
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.015352641	0.9831295808919146
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.015352641	0.9831295808919146
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.015280772000000001	0.9785273408050709
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.015280772000000001	0.9785273408050709
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.015280772000000001	0.9785273408050709
MOWAT-WILSON SYNDROME; MOWS	0.015251190999999999	0.9766330767411637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.015251190999999997	0.9766330767411637
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.015147172	0.9699720627908738
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.015047312	0.9635773766943341
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.014981483	0.9593619171404675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.014981483	0.9593619171404675
SIMOSA CRANIOFACIAL SYNDROME	0.014759040000000001	0.9451174432833415
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.9417145430312874
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.9417145430312874
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.9417145430312874
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.9417145430312874
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.9417145430312874
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.9417145430312874
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.9417145430312874
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.9417145430312874
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.9417145430312874
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.9417145430312874
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0147059	0.9417145430312874
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.9417145430312874
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.9417145430312874
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.014501123	0.9286013381966074
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.014501123	0.9286013381966074
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.014501123	0.9286013381966074
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.014501123	0.9286013381966074
MEHMO SYNDROME; MEHMO	0.014501123	0.9286013381966074
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.014501123	0.9286013381966074
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.014501123	0.9286013381966074
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.014501123	0.9286013381966074
JOUBERT SYNDROME 10	0.014439022	0.9246246067597839
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.014439022	0.9246246067597839
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.014417833000000001	0.9232677371052718
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.014367522999999998	0.9200460601824103
COFFIN-SIRIS SYNDROME 4; CSS4	0.014367522999999998	0.9200460601824103
LUSCAN-LUMISH SYNDROME; LLS	0.014367522999999998	0.9200460601824103
KABUKI SYNDROME 1	0.014367522999999998	0.9200460601824103
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.014367522999999998	0.9200460601824103
COFFIN-SIRIS SYNDROME 3; CSS3	0.014367522999999998	0.9200460601824103
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.014233323	0.9114523602609642
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.014233323	0.9114523602609642
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.01420343	0.9095381168052875
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.01420343	0.9095381168052875
STUVE-WIEDEMANN SYNDROME	0.01420343	0.9095381168052875
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.01420343	0.9095381168052875
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01420343	0.9095381168052875
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.014137601	0.9053226572514209
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.014137601	0.9053226572514209
SECKEL SYNDROME 1; SCKL1	0.014005591	0.8968691972914347
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.014005591	0.8968691972914347
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.014005591	0.8968691972914347
FRYNS SYNDROME; FRNS	0.014005591	0.8968691972914347
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.013878932999999998	0.8887584607441131
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.013862223	0.8876884106272177
WITTEVEEN-KOLK SYNDROME	0.013862223	0.8876884106272177
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.013862223	0.8876884106272177
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.013862223	0.8876884106272177
MENTAL RETARDATION, X-LINKED 1	0.013657240999999999	0.874562078307561
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.013657240999999999	0.874562078307561
BENT BONE DYSPLASIA SYNDROME; BBDS	0.013595139999999999	0.8705853468707373
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.013595139999999999	0.8705853468707373
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.013585372	0.8699598382207173
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.013585372	0.8699598382207173
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.013585372	0.8699598382207173
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.013585372	0.8699598382207173
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.013585372	0.8699598382207173
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.013585372	0.8699598382207173
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.013585372	0.8699598382207173
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.013573951	0.8692284772162252
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.013523640999999998	0.866006800293364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.013523640999999998	0.866006800293364
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.013451771999999999	0.8614045602065202
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.013387533	0.8572909187068646
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.013387533	0.8572909187068646
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.013387533	0.8572909187068646
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.013387533	0.8572909187068646
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.013387533	0.8572909187068646
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.013387533	0.8572909187068646
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.013387533	0.8572909187068646
COHEN-GIBSON SYNDROME; COGIS	0.013317572	0.8528108602850738
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.013253932999999999	0.8487356406926674
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.013253932999999999	0.8487356406926674
HEART AND BRAIN MALFORMATION SYNDROME	0.013170782999999998	0.8434110047130232
WIEDEMANN-STEINER SYNDROME; WDSTS	0.013170782999999998	0.8434110047130232
DIGEORGE SYNDROME; DGS	0.013119733000000001	0.8401419407712212
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.013119733000000001	0.8401419407712212
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.01308984	0.8382276973155446
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.01308984	0.8382276973155446
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.01308984	0.8382276973155446
TEEBI-SHALTOUT SYNDROME; TBSH	0.01308984	0.8382276973155446
OROFACIAL CLEFT 15	0.01308984	0.8382276973155446
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.01308984	0.8382276973155446
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.013018341	0.8336491507381713
COFFIN-LOWRY SYNDROME; CLS	0.013018341	0.8336491507381713
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.013018341	0.8336491507381713
COHEN SYNDROME	0.013018341	0.8336491507381713
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.012963181999999998	0.8301169607682228
DESBUQUOIS DYSPLASIA 2; DBQD2	0.012946472	0.8290469106513275
PEROXISOME BIOGENESIS DISORDER 3B	0.012946472	0.8290469106513275
WARSAW BREAKAGE SYNDROME; WABS	0.012946472	0.8290469106513275
Mental retardation, autosomal dominant 21	0.012946472	0.8290469106513275
KBG SYNDROME	0.012748633	0.8163779911374748
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.01274149	0.8159205783316708
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.012658200000000001	0.8105869772403349
PERIODONTITIS, AGGRESSIVE, 1	0.012658200000000001	0.8105869772403349
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.012658200000000001	0.8105869772403349
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.012658200000000001	0.8105869772403349
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.012658200000000001	0.8105869772403349
TRICHILEMMAL CYST 1	0.012658200000000001	0.8105869772403349
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.012658200000000001	0.8105869772403349
MARFANOID HYPERMOBILITY SYNDROME	0.012658200000000001	0.8105869772403349
SYRINGOMAS, MULTIPLE	0.012658200000000001	0.8105869772403349
MUCOPOLYSACCHARIDOSIS TYPE IX	0.012658200000000001	0.8105869772403349
ACROMIAL DIMPLES	0.012658200000000001	0.8105869772403349
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.012658200000000001	0.8105869772403349
FUTCHER LINE	0.012658200000000001	0.8105869772403349
DERMAL RIDGES, PATTERNLESS	0.012658200000000001	0.8105869772403349
LICHEN PLANUS, FAMILIAL	0.012658200000000001	0.8105869772403349
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.012658200000000001	0.8105869772403349
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.012658200000000001	0.8105869772403349
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.012658200000000001	0.8105869772403349
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.012658200000000001	0.8105869772403349
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.012658200000000001	0.8105869772403349
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.012658200000000001	0.8105869772403349
PARANA HARD-SKIN SYNDROME	0.012658200000000001	0.8105869772403349
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.012658200000000001	0.8105869772403349
SHORT SYNDROME	0.012658200000000001	0.8105869772403349
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.012658200000000001	0.8105869772403349
PATELLA APLASIA-HYPOPLASIA	0.012658200000000001	0.8105869772403349
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.012658200000000001	0.8105869772403349
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.012658200000000001	0.8105869772403349
CAROTENEMIA, FAMILIAL	0.012658200000000001	0.8105869772403349
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.012658200000000001	0.8105869772403349
PILONIDAL SINUS	0.012658200000000001	0.8105869772403349
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.012658200000000001	0.8105869772403349
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.012658200000000001	0.8105869772403349
TYROSINE TRANSAMINASE DEFICIENCY	0.012658200000000001	0.8105869772403349
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.012658200000000001	0.8105869772403349
SAY SYNDROME	0.012658200000000001	0.8105869772403349
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.012658200000000001	0.8105869772403349
KYRLE DISEASE	0.012658200000000001	0.8105869772403349
PSEUDOATROPHODERMA COLLI	0.012658200000000001	0.8105869772403349
#300299 NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX;;XLN	0.012658200000000001	0.8105869772403349
LENTIGINES	0.012658200000000001	0.8105869772403349
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.012658200000000001	0.8105869772403349
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.012658200000000001	0.8105869772403349
PRENATAL BOWING	0.012658200000000001	0.8105869772403349
INSECT STINGS, HYPERSENSITIVITY TO	0.012658200000000001	0.8105869772403349
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.012658200000000001	0.8105869772403349
KERATOSIS, FAMILIAL ACTINIC	0.012658200000000001	0.8105869772403349
#162091 SCHWANNOMATOSIS;;NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS	0.012658200000000001	0.8105869772403349
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.012658200000000001	0.8105869772403349
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.012658200000000001	0.8105869772403349
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.012658200000000001	0.8105869772403349
DERMATOSIS PAPULOSA NIGRA	0.012658200000000001	0.8105869772403349
GLOMUVENOUS MALFORMATIONS	0.012658200000000001	0.8105869772403349
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.012658200000000001	0.8105869772403349
CALLOSITIES, HEREDITARY PAINFUL	0.012658200000000001	0.8105869772403349
COMEDONES, FAMILIAL DYSKERATOTIC	0.012658200000000001	0.8105869772403349
FASCIAL DYSTROPHY, CONGENITAL	0.012658200000000001	0.8105869772403349
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.012658200000000001	0.8105869772403349
131600 EPIDERMOID CYSTS	0.012658200000000001	0.8105869772403349
PIGMENTED PURPURIC ERUPTION	0.012658200000000001	0.8105869772403349
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.012543651	0.803251658817818
MENTAL RETARDATION, X-LINKED 14	0.012543651	0.803251658817818
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.012543651	0.803251658817818
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.012543651	0.803251658817818
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.012543651	0.803251658817818
MENTAL RETARDATION, X-LINKED 100	0.012543651	0.803251658817818
MARSHALL-SMITH SYNDROME; MRSHSS	0.012473689999999999	0.7987716003960273
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.012471782	0.7986494187309744
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.012471782	0.7986494187309744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.012471782	0.7986494187309744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.012471782	0.7986494187309744
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.012471782	0.7986494187309744
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.012410050999999998	0.7946963808036209
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.012410050999999998	0.7946963808036209
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.012410050999999998	0.7946963808036209
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.012410050999999998	0.7946963808036209
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.012410050999999998	0.7946963808036209
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.012338182	0.7900941407167773
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.012326900999999998	0.7893717448239767
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.012326900999999998	0.7893717448239767
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.012203982	0.7815004407953309
#614976 CARPENTER SYNDROME 2; CRPT2	0.012203982	0.7815004407953309
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.012203982	0.7815004407953309
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.012203982	0.7815004407953309
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.012203982	0.7815004407953309
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.012132483	0.7769218942179575
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.012132483	0.7769218942179575
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.011921460999999998	0.7634087813653235
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.011921460999999998	0.7634087813653235
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.011904751	0.7623387312484283
POTOCKI-SHAFFER SYNDROME	0.011904751	0.7623387312484283
FILIPPI SYNDROME; FLPIS	0.011904751	0.7623387312484283
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.011849591999999999	0.7588065412784799
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.011849591999999999	0.7588065412784799
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.011832882000000001	0.7577364911615846
Aarskog-Scott syndrome	0.011832882000000001	0.7577364911615846
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.011832882000000001	0.7577364911615846
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.011832882000000001	0.7577364911615846
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.011832882000000001	0.7577364911615846
SOTOS SYNDROME 3	0.0116279	0.7446101588419278
ACHALASIA-MICROCEPHALY SYNDROME	0.011494299999999999	0.7360548808277307
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.011494299999999999	0.7360548808277307
POLYCYSTIC OVARY SYNDROME 1	0.011494299999999999	0.7360548808277307
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.011494299999999999	0.7360548808277307
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.011494299999999999	0.7360548808277307
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.011494299999999999	0.7360548808277307
CARNEY COMPLEX, TYPE 1; CNC1	0.011494299999999999	0.7360548808277307
#307150 HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2;;CHROMOSOME Xq27.1 INTERCHROMOSOMAL INSERTION SYNDROME;;CGH;;HCG	0.011494299999999999	0.7360548808277307
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.011494299999999999	0.7360548808277307
FRONTOMETAPHYSEAL DYSPLASIA	0.011494299999999999	0.7360548808277307
OVARIAN DYSGENESIS 2; ODG2	0.011494299999999999	0.7360548808277307
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.011494299999999999	0.7360548808277307
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.011494299999999999	0.7360548808277307
#158330 MULLERIAN APLASIA AND HYPERANDROGENISM;;MULLERIAN DUCT FAILURE AND HYPERANDROGENISM	0.011494299999999999	0.7360548808277307
46,XY SEX REVERSAL 6; SRXY6	0.011494299999999999	0.7360548808277307
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.011494299999999999	0.7360548808277307
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.011494299999999999	0.7360548808277307
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.011494299999999999	0.7360548808277307
CRANIORHINY	0.011494299999999999	0.7360548808277307
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.011494299999999999	0.7360548808277307
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.011494299999999999	0.7360548808277307
HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	0.011494299999999999	0.7360548808277307
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.011494299999999999	0.7360548808277307
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.011494299999999999	0.7360548808277307
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.011411149999999998	0.7307302448480864
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0113601	0.7274611809062844
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0113601	0.7274611809062844
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.0113601	0.7274611809062844
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.0113601	0.7274611809062844
SCARF SYNDROME	0.0113601	0.7274611809062844
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.0113601	0.7274611809062844
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.011288601	0.7228826343289111
CHROMOSOME 18Q DELETION SYNDROME	0.011288600999999999	0.722882634328911
ACROCALLOSAL SYNDROME; ACLS	0.011288600999999999	0.722882634328911
CRANIOFRONTONASAL SYNDROME; CFNS	0.011216732	0.7182803942420674
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.011216732	0.7182803942420674
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.011213310999999998	0.7180613253342336
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.011141442	0.7134590852473899
SWEENEY-COX SYNDROME; SWCOS	0.011141442	0.7134590852473899
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.011141442	0.7134590852473899
HOLOPROSENCEPHALY 2; HPE2	0.011069942999999999	0.7088805386700165
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.011069942999999999	0.7088805386700165
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.011069942999999999	0.7088805386700165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.011069942999999999	0.7088805386700165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.011069942999999999	0.7088805386700165
CODAS SYNDROME	0.011069942999999999	0.7088805386700165
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.011069942999999999	0.7088805386700165
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.011069942999999999	0.7088805386700165
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.011069942999999999	0.7088805386700165
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.011069942999999999	0.7088805386700165
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.011069942999999999	0.7088805386700165
Glycosylphosphatidylinositol biosynthesis defect 18	0.011069942999999999	0.7088805386700165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.011069942999999999	0.7088805386700165
HYPEREKPLEXIA 4; HKPX4	0.011018893	0.7056114747282146
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.011018893	0.7056114747282146
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.011018893	0.7056114747282146
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.011005709999999998	0.7047672813894333
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.011005709999999998	0.7047672813894333
PARKINSON DISEASE, LATE-ONSET; PD	0.011005709999999998	0.7047672813894333
POSTAXIAL OLIGODACTYLY, TETRAMELIC	0.010989	0.703697231272538
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.010989	0.703697231272538
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.010989	0.703697231272538
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.010989	0.703697231272538
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.010989	0.703697231272538
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.010989	0.703697231272538
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.010989	0.703697231272538
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.010989	0.703697231272538
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.010989	0.703697231272538
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.010989	0.703697231272538
268650 RUDIGER SYNDROME	0.010989	0.703697231272538
CRANIOECTODERMAL DYSPLASIA 1	0.010989	0.703697231272538
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.010989	0.703697231272538
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.010989	0.703697231272538
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.010989	0.703697231272538
BASAN SYNDROME	0.010989	0.703697231272538
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.010707343	0.6856608993889699
ARTERIAL TORTUOSITY SYNDROME	0.01037285	0.6642411343530208
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.01037285	0.6642411343530208
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.01037285	0.6642411343530208
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01037285	0.6642411343530208
MEIER-GORLIN SYNDROME 1; MGORS1	0.010297559999999999	0.6594198253583434
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.010297559999999999	0.6594198253583434
MEIER-GORLIN SYNDROME 3; MGORS3	0.010297559999999999	0.6594198253583434
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.010297559999999999	0.6594198253583434
MEIER-GORLIN SYNDROME 5; MGORS5	0.010297559999999999	0.6594198253583434
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.010297559999999999	0.6594198253583434
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.010226060999999998	0.65484127878097
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.010226060999999998	0.65484127878097
HYPOPHOSPHATASIA, INFANTILE	0.010226060999999998	0.65484127878097
TENORIO SYNDROME; TNORS	0.010226060999999998	0.65484127878097
MUCOPOLYSACCHARIDOSIS, TYPE II	0.010175011	0.651572214839168
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.010175011	0.651572214839168
GAPO SYNDROME; GAPOS	0.010175011	0.651572214839168
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.010154192	0.6502390386941264
NIEMANN-PICK DISEASE, TYPE A	0.010154192	0.6502390386941264
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.010154192	0.6502390386941264
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.010103142	0.6469699747523243
#300555 DENT DISEASE 2	0.010103142	0.6469699747523243
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009999193	0.64031344335788
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.009999193	0.64031344335788
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.009999193	0.64031344335788
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.009999193	0.64031344335788
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.009999193	0.64031344335788
WEBB-DATTANI SYNDROME; WEDAS	0.009956353	0.6375701191802737
MIRAGE SYNDROME; MIRAGE	0.009956353	0.6375701191802737
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009956353	0.6375701191802737
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.009956353	0.6375701191802737
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.009956353	0.6375701191802737
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.009593753	0.614350479899227
CHROMOSOME 1p35 DELETION SYNDROME	0.009593753	0.614350479899227
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.009310309999999999	0.5961997788050798
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.009310309999999999	0.5961997788050798
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.009310309999999999	0.5961997788050798
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00925926	0.5929307148632779
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00925926	0.5929307148632779
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00925926	0.5929307148632779
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00925926	0.5929307148632779
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00925926	0.5929307148632779
#156550 KNIEST DYSPLASIA	0.00925926	0.5929307148632779
BRITTLE CORNEA SYNDROME 2; BCS2	0.00925926	0.5929307148632779
MUSCULAR HYPERTONIA, LETHAL	0.00925926	0.5929307148632779
HUNTER-MACDONALD SYNDROME	0.00925926	0.5929307148632779
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00925926	0.5929307148632779
OMODYSPLASIA 1; OMOD1	0.00925926	0.5929307148632779
LOEYS-DIETZ SYNDROME 3; LDS3	0.00925926	0.5929307148632779
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00925926	0.5929307148632779
#600972 ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE	0.00925926	0.5929307148632779
EHLERS-DANLOS SYNDROME, TYPE I	0.00925926	0.5929307148632779
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.00925926	0.5929307148632779
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00925926	0.5929307148632779
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00925926	0.5929307148632779
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.009112470999999999	0.5835308592912272
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.009112470999999999	0.5835308592912272
LOWE OCULOCEREBRORENAL SYNDROME	0.009112470999999999	0.5835308592912272
AUTISM, SUSCEPTIBILITY TO, 18	0.009112470999999999	0.5835308592912272
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.009112470999999999	0.5835308592912272
GITELMAN SYNDROME	0.009112470999999999	0.5835308592912272
AL-RAQAD SYNDROME; ARS	0.009083442	0.5816719433819898
OROFACIODIGITAL SYNDROME XIV; OFD14	0.009083442	0.5816719433819898
HADZISELIMOVIC SYNDROME	0.009083442	0.5816719433819898
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.009040602	0.5789286192043834
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.009040602	0.5789286192043834
CHOPS SYNDROME; CHOPS	0.009040602	0.5789286192043834
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.009040602	0.5789286192043834
POPOV-CHANG SYNDROME; POPCHAS	0.009040602	0.5789286192043834
300270 ADRENOMYODYSTROPHY	0.009040602	0.5789286192043834
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.009040602	0.5789286192043834
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.009040602	0.5789286192043834
BAKER-GORDON SYNDROME; BAGOS	0.009040602	0.5789286192043834
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.009040602	0.5789286192043834
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.008885603	0.5690030238681371
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.008885603	0.5690030238681371
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.008885603	0.5690030238681371
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.008885603	0.5690030238681371
UROFACIAL SYNDROME	0.00819672	0.524889359315337
MYXEDEMA	0.00819672	0.524889359315337
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	0.524889359315337
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00819672	0.524889359315337
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00819672	0.524889359315337
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00819672	0.524889359315337
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00819672	0.524889359315337
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00819672	0.524889359315337
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00819672	0.524889359315337
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.00819672	0.524889359315337
ADIPOSIS DOLOROSA	0.00819672	0.524889359315337
GASTROESOPHAGEAL REFLUX	0.00819672	0.524889359315337
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00819672	0.524889359315337
FG SYNDROME 2; FGS2	0.00819672	0.524889359315337
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00819672	0.524889359315337
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00819672	0.524889359315337
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	0.524889359315337
ANAL SPHINCTER DYSPLASIA; ASDP	0.00819672	0.524889359315337
UROFACIAL SYNDROME 2	0.00819672	0.524889359315337
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00819672	0.524889359315337
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00819672	0.524889359315337
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00819672	0.524889359315337
PORPHYRIA VARIEGATA	0.00819672	0.524889359315337
#614266 BARRETT ESOPHAGUS;;BARRETT METAPLASIAADENOCARCINOMA OF ESOPHAGUS, INCLUDED	0.00819672	0.524889359315337
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	0.524889359315337
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00819672	0.524889359315337
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00819672	0.524889359315337
MEIER-GORLIN SYNDROME 2; MGORS2	0.00819672	0.524889359315337
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00819672	0.524889359315337
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	0.524889359315337
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	0.524889359315337
VISCERAL MYOPATHY; VSCM	0.00819672	0.524889359315337
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00819672	0.524889359315337
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.008041721	0.5149637639790905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.007898353	0.5057829773148735
AICARDI-GOUTIERES SYNDROME 7	0.007898353	0.5057829773148735
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.007898353	0.5057829773148735
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.007898353	0.5057829773148735
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.007898353	0.5057829773148735
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.007898353	0.5057829773148735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.007898353	0.5057829773148735
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.007898353	0.5057829773148735
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.007898353	0.5057829773148735
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.007898353	0.5057829773148735
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.007898353	0.5057829773148735
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.007898353	0.5057829773148735
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.007898353	0.5057829773148735
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007898353	0.5057829773148735
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.007898353	0.5057829773148735
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.007898353	0.5057829773148735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.007898353	0.5057829773148735
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.007898353	0.5057829773148735
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.007898353	0.5057829773148735
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.007898353	0.5057829773148735
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.007898353	0.5057829773148735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.007898353	0.5057829773148735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.007898353	0.5057829773148735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.007898353	0.5057829773148735
RAYNAUD-CLAES SYNDROME; MRXSRC	0.007898353	0.5057829773148735
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.007125970000000001	0.45632226400320025
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0070544710000000005	0.45174371742582703
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.0070544710000000005	0.45174371742582703
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.007054471	0.4517437174258269
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.007054471	0.4517437174258269
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.007054471	0.4517437174258269
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.007054471	0.4517437174258269
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.006982602	0.44714147733898324
OPTIC ATROPHY 11; OPA11	0.006982602	0.44714147733898324
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.006982602	0.44714147733898324
MUCOLIPIDOSIS IV; ML4	0.006982602	0.44714147733898324
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006982602	0.44714147733898324
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.006982602	0.44714147733898324
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.006982602	0.44714147733898324
YOU-HOOVER-FONG SYNDROME; YHFS	0.006982602	0.44714147733898324
JOUBERT SYNDROME 24	0.006982602	0.44714147733898324
SPINOCEREBELLAR ATAXIA 47; SCA47	0.006939171	0.44436030758273626
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.006784763	0.4344725578251305
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.006784763	0.4344725578251305
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.006784763	0.4344725578251305
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.006784763	0.4344725578251305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.006784763	0.4344725578251305
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.006784763	0.4344725578251305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.006784763	0.4344725578251305
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.006784763	0.4344725578251305
LISSENCEPHALY 8; LIS8	0.006784763	0.4344725578251305
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.006784763	0.4344725578251305
MENTAL RETARDATION, X-LINKED 104; MRX104	0.006784763	0.4344725578251305
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006784763	0.4344725578251305
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.006784763	0.4344725578251305
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.006784763	0.4344725578251305
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.006784763	0.4344725578251305
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.006784763	0.4344725578251305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.006784763	0.4344725578251305
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.006784763	0.4344725578251305
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.006784763	0.4344725578251305
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.006784763	0.4344725578251305
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.006784763	0.4344725578251305
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.006784763	0.4344725578251305
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.006784763	0.4344725578251305
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.006784763	0.4344725578251305
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.006784763	0.4344725578251305
MENTAL RETARDATION, X-LINKED 91; MRX91	0.006784763	0.4344725578251305
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.006784763	0.4344725578251305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.006784763	0.4344725578251305
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006784763	0.4344725578251305
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.006784763	0.4344725578251305
MENTAL RETARDATION, X-LINKED 103	0.006784763	0.4344725578251305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.006784763	0.4344725578251305
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00613872	0.39310221744993673
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00613872	0.39310221744993673
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00613872	0.39310221744993673
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.005940881	0.380433297936084
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.005940881	0.380433297936084
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.005940881	0.380433297936084
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.005940881	0.380433297936084
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.005940881	0.380433297936084
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.005940881	0.380433297936084
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.005869012	0.37583105784924026
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.005869012	0.37583105784924026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.005869012	0.37583105784924026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.005869012	0.37583105784924026
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.005869012	0.37583105784924026
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.005869012	0.37583105784924026
LEIGH SYNDROME; LS	0.005682213	0.3638691014287762
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.005682213	0.3638691014287762
SALLA DISEASE	0.005682213	0.3638691014287762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.005682213	0.3638691014287762
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.005682213	0.3638691014287762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.005682213	0.3638691014287762
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.005682213	0.3638691014287762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.005682213	0.3638691014287762
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.005682213	0.3638691014287762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.005682213	0.3638691014287762
OPTICOCOCHLEODENTATE DEGENERATION	0.00502513	0.32179179796019375
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00502513	0.32179179796019375
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00502513	0.32179179796019375
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00502513	0.32179179796019375
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00502513	0.32179179796019375
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00502513	0.32179179796019375
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00502513	0.32179179796019375
WARBURG MICRO SYNDROME 2; WARBM2	0.00502513	0.32179179796019375
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00502513	0.32179179796019375
RECOMBINANT CHROMOSOME 8 SYNDROME	0.004974063	0.31852164539768624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004974063	0.31852164539768624
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.004974063	0.31852164539768624
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004974063	0.31852164539768624
TEMTAMY SYNDROME; TEMTYS	0.004974063	0.31852164539768624
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.004974063	0.31852164539768624
MEND SYNDROME; MEND	0.004974063	0.31852164539768624
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.004974063	0.31852164539768624
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004974063	0.31852164539768624
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004974063	0.31852164539768624
ZTTK SYNDROME; ZTTKS	0.004974063	0.31852164539768624
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.004974063	0.31852164539768624
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.004974063	0.31852164539768624
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.004974063	0.31852164539768624
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.004974063	0.31852164539768624
ADENYLOSUCCINASE DEFICIENCY	0.004974063	0.31852164539768624
VICI SYNDROME; VICIS	0.004974063	0.31852164539768624
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004974063	0.31852164539768624
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004974063	0.31852164539768624
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004974063	0.31852164539768624
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.004974063	0.31852164539768624
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.004974063	0.31852164539768624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004974063	0.31852164539768624
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004974063	0.31852164539768624
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004974063	0.31852164539768624
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004974063	0.31852164539768624
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.004974063	0.31852164539768624
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.004974063	0.31852164539768624
CHROMOSOME 10Q26 DELETION SYNDROME	0.004974063	0.31852164539768624
JABERI-ELAHI SYNDROME; JABELS	0.004974063	0.31852164539768624
C SYNDROME	0.004974063	0.31852164539768624
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0049098300000000004	0.3144083881171031
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.004838331	0.30982984153972976
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.004838331	0.30982984153972976
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.004838331	0.30982984153972976
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004838331	0.30982984153972976
EPISODIC ATAXIA, TYPE 6	0.004838331	0.30982984153972976
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.004766462	0.30522760145288597
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.004766462	0.30522760145288597
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004766462	0.30522760145288597
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.004766462	0.30522760145288597
SPINOCEREBELLAR ATAXIA 5; SCA5	0.004766462	0.30522760145288597
MARINESCO-SJOGREN SYNDROME; MSS	0.004766462	0.30522760145288597
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.004766462	0.30522760145288597
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.004766462	0.30522760145288597
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.004766462	0.30522760145288597
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.004766462	0.30522760145288597
PEROXISOME BIOGENESIS DISORDER 6B	0.004766462	0.30522760145288597
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.004766462	0.30522760145288597
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.004568623	0.2925586819390332
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004568623	0.2925586819390332
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.004568623	0.2925586819390332
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.004568623	0.2925586819390332
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.004568623	0.2925586819390332
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.004568623	0.2925586819390332
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.004568623	0.2925586819390332
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.004568623	0.2925586819390332
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.004130181	0.2644823855086398
GLUTAMINE DEFICIENCY, CONGENITAL	0.004130181	0.2644823855086398
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.004130181	0.2644823855086398
MARDEN-WALKER SYNDROME	0.004130181	0.2644823855086398
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.004130181	0.2644823855086398
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.004130181	0.2644823855086398
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.004130181	0.2644823855086398
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004130181	0.2644823855086398
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.004130181	0.2644823855086398
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.004130181	0.2644823855086398
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004130181	0.2644823855086398
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.004130181	0.2644823855086398
LISSENCEPHALY, X-LINKED, 2	0.004130181	0.2644823855086398
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.004130181	0.2644823855086398
OROFACIODIGITAL SYNDROME VI	0.004058312	0.25988014542179594
JOUBERT SYNDROME 14	0.004058312	0.25988014542179594
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.004058312	0.25988014542179594
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.004058312	0.25988014542179594
DIAPHANOSPONDYLODYSOSTOSIS	0.004058312	0.25988014542179594
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.004058312	0.25988014542179594
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.004058312	0.25988014542179594
NOONAN SYNDROME 11; NS11	0.004058312	0.25988014542179594
XIA-GIBBS SYNDROME	0.004058312	0.25988014542179594
GOLDBERG-SHPRINTZEN SYNDROME	0.004058312	0.25988014542179594
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.004058312	0.25988014542179594
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.004058312	0.25988014542179594
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.004058312	0.25988014542179594
LAMB-SHAFFER SYNDROME	0.004058312	0.25988014542179594
PEROXISOME BIOGENESIS DISORDER 10B	0.004058312	0.25988014542179594
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004058312	0.25988014542179594
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004058312	0.25988014542179594
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.004058312	0.25988014542179594
LARSEN-LIKE SYNDROME	0.004058312	0.25988014542179594
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.004058312	0.25988014542179594
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.004058312	0.25988014542179594
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004058312	0.25988014542179594
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.004058312	0.25988014542179594
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.004058312	0.25988014542179594
CHROMOSOME 16Q22 DELETION SYNDROME	0.004058312	0.25988014542179594
RITSCHER-SCHINZEL SYNDROME 1	0.004058312	0.25988014542179594
NOONAN SYNDROME 6; NS6	0.004058312	0.25988014542179594
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.004058312	0.25988014542179594
MEVALONIC ACIDURIA; MEVA	0.004058312	0.25988014542179594
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00392258	0.2511883415638395
LESCH-NYHAN SYNDROME; LNS	0.00392258	0.2511883415638395
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00392258	0.2511883415638395
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00392258	0.2511883415638395
SPINOCEREBELLAR ATAXIA 13	0.00392258	0.2511883415638395
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00392258	0.2511883415638395
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00392258	0.2511883415638395
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00392258	0.2511883415638395
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00392258	0.2511883415638395
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00392258	0.2511883415638395
#602398 DESMOSTEROLOSIS	0.0038604729999999997	0.24721122590794326
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.0038604729999999997	0.24721122590794326
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.0038604729999999997	0.24721122590794326
GLYCEROL KINASE DEFICIENCY; GKD	0.0038604729999999997	0.24721122590794326
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.0038604729999999997	0.24721122590794326
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.0038604729999999997	0.24721122590794326
GLASS SYNDROME	0.0038604729999999997	0.24721122590794326
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0038604729999999997	0.24721122590794326
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0038604729999999997	0.24721122590794326
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0038604729999999997	0.24721122590794326
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.003724741	0.23851942204998677
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.003724741	0.23851942204998677
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.003724741	0.23851942204998677
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.003724741	0.23851942204998677
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.003724741	0.23851942204998677
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.003724741	0.23851942204998677
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.003724741	0.23851942204998677
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003724741	0.23851942204998677
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.003724741	0.23851942204998677
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.003724741	0.23851942204998677
COCKAYNE SYNDROME A; CSA	0.003724741	0.23851942204998677
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.003724741	0.23851942204998677
OCULODENTODIGITAL DYSPLASIA; ODDD	0.003724741	0.23851942204998677
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.003724741	0.23851942204998677
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.003724741	0.23851942204998677
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.003724741	0.23851942204998677
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.003724741	0.23851942204998677
CEREBELLOPARENCHYMAL DISORDER II	0.003724741	0.23851942204998677
LISSENCEPHALY, X-LINKED, 1; LISX1	0.003724741	0.23851942204998677
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.003724741	0.23851942204998677
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.003724741	0.23851942204998677
GLUTATHIONE SYNTHETASE DEFICIENCY	0.003724741	0.23851942204998677
SNEDDON SYNDROME	0.003724741	0.23851942204998677
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.003724741	0.23851942204998677
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.003724741	0.23851942204998677
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.003724741	0.23851942204998677
SUPRABULBAR PARESIS, CONGENITAL	0.003724741	0.23851942204998677
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.003724741	0.23851942204998677
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0036528719999999997	0.23391718196314298
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0036528719999999997	0.23391718196314298
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0036528719999999997	0.23391718196314298
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0036528719999999997	0.23391718196314298
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0036528719999999997	0.23391718196314298
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.0036528719999999997	0.23391718196314298
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.0036528719999999997	0.23391718196314298
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.0036528719999999997	0.23391718196314298
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.0036528719999999997	0.23391718196314298
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.0036528719999999997	0.23391718196314298
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0036528719999999997	0.23391718196314298
PELLAGRA-LIKE SYNDROME	0.0036528719999999997	0.23391718196314298
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.0036528719999999997	0.23391718196314298
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.0036528719999999997	0.23391718196314298
CAMPOMELIC DYSPLASIA	0.00321443	0.20584088553274948
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00321443	0.20584088553274948
COFFIN-SIRIS SYNDROME 10; CSS10	0.00321443	0.20584088553274948
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00321443	0.20584088553274948
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00321443	0.20584088553274948
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00321443	0.20584088553274948
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00321443	0.20584088553274948
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00321443	0.20584088553274948
JACOBSEN SYNDROME	0.00321443	0.20584088553274948
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00321443	0.20584088553274948
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00321443	0.20584088553274948
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00321443	0.20584088553274948
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00321443	0.20584088553274948
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00321443	0.20584088553274948
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00321443	0.20584088553274948
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00321443	0.20584088553274948
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00321443	0.20584088553274948
VERVERI-BRADY SYNDROME; VERBRAS	0.00321443	0.20584088553274948
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00321443	0.20584088553274948
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00321443	0.20584088553274948
PSEUDOTRISOMY 13 SYNDROME	0.00321443	0.20584088553274948
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00321443	0.20584088553274948
SIFRIM-HITZ-WEISS SYNDROME	0.00321443	0.20584088553274948
Myhre syndrome	0.003016591	0.19317196601889677
#613707 LEOPARD SYNDROME 3; LPRD3	0.003016591	0.19317196601889677
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.003016591	0.19317196601889677
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.003016591	0.19317196601889677
OROFACIODIGITAL SYNDROME I; OFD1	0.003016591	0.19317196601889677
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.003016591	0.19317196601889677
AYME-GRIPP SYNDROME; AYGRP	0.003016591	0.19317196601889677
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.003016591	0.19317196601889677
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.003016591	0.19317196601889677
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.003016591	0.19317196601889677
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.003016591	0.19317196601889677
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.003016591	0.19317196601889677
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.003016591	0.19317196601889677
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.003016591	0.19317196601889677
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.003016591	0.19317196601889677
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.0029447220000000003	0.18856972593205304
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0029447220000000003	0.18856972593205304
CHAR SYNDROME	0.0029447220000000003	0.18856972593205304
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0029447220000000003	0.18856972593205304
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0029447220000000003	0.18856972593205304
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0029447220000000003	0.18856972593205304
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0029447220000000003	0.18856972593205304
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.0029447220000000003	0.18856972593205304
HARTSFIELD SYNDROME; HRTFDS	0.0029447220000000003	0.18856972593205304
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0029447220000000003	0.18856972593205304
CEREBELLOFACIODENTAL SYNDROME	0.0029447220000000003	0.18856972593205304
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0029447220000000003	0.18856972593205304
ELSAHY-WATERS SYNDROME; ESWS	0.0029447220000000003	0.18856972593205304
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0029447220000000003	0.18856972593205304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0029447220000000003	0.18856972593205304
DIAMOND-BLACKFAN ANEMIA 5	0.0029447220000000003	0.18856972593205304
ALAZAMI SYNDROME; ALAZS	0.0029447220000000003	0.18856972593205304
CREE MENTAL RETARDATION SYNDROME	0.0029447220000000003	0.18856972593205304
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0029447220000000003	0.18856972593205304
CHROMOSOME 15Q14 DELETION SYNDROME	0.0029447220000000003	0.18856972593205304
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0029447220000000003	0.18856972593205304
FRONTOOCULAR SYNDROME	0.0029447220000000003	0.18856972593205304
NOONAN SYNDROME 5; NS5	0.0029447220000000003	0.18856972593205304
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.0029447220000000003	0.18856972593205304
Retinitis pigmentosa with or without skeletal anomalies	0.0029447220000000003	0.18856972593205304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0029447220000000003	0.18856972593205304
NOONAN SYNDROME 3; NS3	0.0029447220000000003	0.18856972593205304
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0029447220000000003	0.18856972593205304
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0029447220000000003	0.18856972593205304
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0029447220000000003	0.18856972593205304
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0029447220000000003	0.18856972593205304
OGDEN SYNDROME; OGDNS	0.0029447220000000003	0.18856972593205304
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.0029447220000000003	0.18856972593205304
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.0029447220000000003	0.18856972593205304
FORSYTHE-WAKELING SYNDROME; FWS	0.0029447220000000003	0.18856972593205304
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.0029447220000000003	0.18856972593205304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0029447220000000003	0.18856972593205304
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0029447220000000003	0.18856972593205304
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0029447220000000003	0.18856972593205304
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0029447220000000003	0.18856972593205304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0029447220000000003	0.18856972593205304
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0028732230000000003	0.18399117935467973
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0028732230000000003	0.18399117935467973
GRISCELLI SYNDROME, TYPE 1	0.0028732230000000003	0.18399117935467973
SHUKLA-VERNON SYNDROME; SHUVER	0.0028732230000000003	0.18399117935467973
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0028732230000000003	0.18399117935467973
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0028732230000000003	0.18399117935467973
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0028732230000000003	0.18399117935467973
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0028732230000000003	0.18399117935467973
INFANTILE LIVER FAILURE SYNDROME 1	0.0028732230000000003	0.18399117935467973
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0028732230000000003	0.18399117935467973
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0028732230000000003	0.18399117935467973
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0028732230000000003	0.18399117935467973
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0028732230000000003	0.18399117935467973
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0028732230000000003	0.18399117935467973
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0028732230000000003	0.18399117935467973
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0028732230000000003	0.18399117935467973
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028732230000000003	0.18399117935467973
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0028732230000000003	0.18399117935467973
PEHO SYNDROME; PEHO	0.0028732230000000003	0.18399117935467973
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0028732230000000003	0.18399117935467973
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0028732230000000003	0.18399117935467973
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0028732230000000003	0.18399117935467973
SCHINDLER DISEASE, TYPE I	0.0028732230000000003	0.18399117935467973
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0028732230000000003	0.18399117935467973
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0028732230000000003	0.18399117935467973
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0028732230000000003	0.18399117935467973
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0028732230000000003	0.18399117935467973
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0028732230000000003	0.18399117935467973
Helsmoortel-van der Aa syndrome	0.0028732230000000003	0.18399117935467973
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0028732230000000003	0.18399117935467973
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0028732230000000003	0.18399117935467973
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0028732230000000003	0.18399117935467973
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0028732230000000003	0.18399117935467973
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0028732230000000003	0.18399117935467973
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0028732230000000003	0.18399117935467973
PYRUVATE CARBOXYLASE DEFICIENCY	0.0028732230000000003	0.18399117935467973
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0028732230000000003	0.18399117935467973
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.0028732230000000003	0.18399117935467973
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0028732230000000003	0.18399117935467973
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0028732230000000003	0.18399117935467973
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0028732230000000003	0.18399117935467973
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.0028732230000000003	0.18399117935467973
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0028732230000000003	0.18399117935467973
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0028732230000000003	0.18399117935467973
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0028732230000000003	0.18399117935467973
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0028732230000000003	0.18399117935467973
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0028732230000000003	0.18399117935467973
XQ25 DUPLICATION SYNDROME	0.0028732230000000003	0.18399117935467973
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.0028732230000000003	0.18399117935467973
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0028732230000000003	0.18399117935467973
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0028732230000000003	0.18399117935467973
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0028732230000000003	0.18399117935467973
CHROMOSOME 5Q12 DELETION SYNDROME	0.0028732230000000003	0.18399117935467973
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0028732230000000003	0.18399117935467973
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.0028732230000000003	0.18399117935467973
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0028732230000000003	0.18399117935467973
TIMOTHY SYNDROME; TS	0.0028732230000000003	0.18399117935467973
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.0028732230000000003	0.18399117935467973
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0028732230000000003	0.18399117935467973
HOLOPROSENCEPHALY 1; HPE1	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.0028732230000000003	0.18399117935467973
KETOADIPICACIDURIA	0.0028732230000000003	0.18399117935467973
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.0028732230000000003	0.18399117935467973
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.0028732230000000003	0.18399117935467973
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.0028732230000000003	0.18399117935467973
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0028732230000000003	0.18399117935467973
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0028732230000000003	0.18399117935467973
FOLATE MALABSORPTION, HEREDITARY	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0028732230000000003	0.18399117935467973
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0028732230000000003	0.18399117935467973
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0028732230000000003	0.18399117935467973
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.0028732230000000003	0.18399117935467973
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0028732230000000003	0.18399117935467973
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0028732230000000003	0.18399117935467973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0028732230000000003	0.18399117935467973
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0028732230000000003	0.18399117935467973
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0028732230000000003	0.18399117935467973
MENTAL RETARDATION, X-LINKED 90	0.0028732230000000003	0.18399117935467973
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0028732230000000003	0.18399117935467973
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0028732230000000003	0.18399117935467973
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0028732230000000003	0.18399117935467973
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0028732230000000003	0.18399117935467973
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0028732230000000003	0.18399117935467973
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0028732230000000003	0.18399117935467973
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0028732230000000003	0.18399117935467973
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0028732230000000003	0.18399117935467973
ADAMS-OLIVER SYNDROME 1; AOS1	0.0028732230000000003	0.18399117935467973
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.0028732230000000003	0.18399117935467973
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0028732230000000003	0.18399117935467973
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0028732230000000003	0.18399117935467973
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0028732230000000003	0.18399117935467973
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0028732230000000003	0.18399117935467973
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0028732230000000003	0.18399117935467973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0028732230000000003	0.18399117935467973
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0028732230000000003	0.18399117935467973
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.0028732230000000003	0.18399117935467973
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.0028732230000000003	0.18399117935467973
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0028732230000000003	0.18399117935467973
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0028732230000000003	0.18399117935467973
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0028732230000000003	0.18399117935467973
JOUBERT SYNDROME 30; JBTS30	0.0028732230000000003	0.18399117935467973
PRADER-WILLI SYNDROME; PWS	0.0028732230000000003	0.18399117935467973
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0028732230000000003	0.18399117935467973
PETTIGREW SYNDROME	0.0028732230000000003	0.18399117935467973
ELEJALDE DISEASE	0.0028732230000000003	0.18399117935467973
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0028732230000000003	0.18399117935467973
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0028732230000000003	0.18399117935467973
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0028732230000000003	0.18399117935467973
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00280899	0.1798779220740965
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00280899	0.1798779220740965
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 31	0.00280899	0.1798779220740965
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.00280899	0.1798779220740965
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00280899	0.1798779220740965
MYASTHENIA GRAVIS; MG	0.00280899	0.1798779220740965
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00280899	0.1798779220740965
#610246 SPINOCEREBELLAR ATAXIA 28; SCA28	0.00280899	0.1798779220740965
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.00280899	0.1798779220740965
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.00280899	0.1798779220740965
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00280899	0.1798779220740965
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00280899	0.1798779220740965
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.00280899	0.1798779220740965
ALLAN-HERNDON-DUDLEY SYNDROME	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00280899	0.1798779220740965
EPISODIC ATAXIA, TYPE 5	0.00280899	0.1798779220740965
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00280899	0.1798779220740965
HUNTINGTON DISEASE-LIKE 2	0.00280899	0.1798779220740965
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00280899	0.1798779220740965
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.00280899	0.1798779220740965
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00280899	0.1798779220740965
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.00280899	0.1798779220740965
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00280899	0.1798779220740965
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00280899	0.1798779220740965
#604432 SPINOCEREBELLAR ATAXIA 11; SCA11	0.00280899	0.1798779220740965
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00280899	0.1798779220740965
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.00280899	0.1798779220740965
LEBER OPTIC ATROPHY AND DYSTONIA	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00280899	0.1798779220740965
#613954 AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS14	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 12	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00280899	0.1798779220740965
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00280899	0.1798779220740965
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00280899	0.1798779220740965
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00280899	0.1798779220740965
#614808 AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	0.00280899	0.1798779220740965
TREMOR, HEREDITARY ESSENTIAL, 1	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00280899	0.1798779220740965
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00280899	0.1798779220740965
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00280899	0.1798779220740965
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00280899	0.1798779220740965
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.00280899	0.1798779220740965
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00280899	0.1798779220740965
#614696 AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17;;AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED	0.00280899	0.1798779220740965
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00280899	0.1798779220740965
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00280899	0.1798779220740965
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00280899	0.1798779220740965
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00280899	0.1798779220740965
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00280899	0.1798779220740965
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 40; SCA40	0.00280899	0.1798779220740965
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00280899	0.1798779220740965
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.00280899	0.1798779220740965
PERRY SYNDROME	0.00280899	0.1798779220740965
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00280899	0.1798779220740965
#118800 PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1;;PAROXYSMAL DYSTONIC CHOREOATHETOSIS; PDC;;CHOREOATHETOSIS, FAMILIAL PAROXYSMAL; FPD1;;MOUNT-REBACK SYNDROME;;CHOREOATHETOSIS, NONKINESIGENIC;;DYSTONIA 8; DYT8	0.00280899	0.1798779220740965
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.00280899	0.1798779220740965
EPISODIC ATAXIA, TYPE 7; EA7	0.00280899	0.1798779220740965
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00280899	0.1798779220740965
WOODHOUSE-SAKATI SYNDROME	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00280899	0.1798779220740965
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00280899	0.1798779220740965
WILSON DISEASE	0.00280899	0.1798779220740965
CHIARI MALFORMATION TYPE I	0.00280899	0.1798779220740965
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.00280899	0.1798779220740965
OPTIC ATROPHY 2	0.00280899	0.1798779220740965
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00280899	0.1798779220740965
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.00280899	0.1798779220740965
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00280899	0.1798779220740965
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00280899	0.1798779220740965
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00280899	0.1798779220740965
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00280899	0.1798779220740965
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00280899	0.1798779220740965
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 42	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 14	0.00280899	0.1798779220740965
SYRINGOMYELIA, ISOLATED	0.00280899	0.1798779220740965
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.00280899	0.1798779220740965
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.00280899	0.1798779220740965
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00280899	0.1798779220740965
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00280899	0.1798779220740965
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00280899	0.1798779220740965
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.00280899	0.1798779220740965
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00280899	0.1798779220740965
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.00280899	0.1798779220740965
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.00280899	0.1798779220740965
#602099 AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00280899	0.1798779220740965
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00280899	0.1798779220740965
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00280899	0.1798779220740965
MACHADO-JOSEPH DISEASE; MJD	0.00280899	0.1798779220740965
HUNTINGTON DISEASE-LIKE 1	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00280899	0.1798779220740965
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00280899	0.1798779220740965
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00280899	0.1798779220740965
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00280899	0.1798779220740965
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00280899	0.1798779220740965
#613435 AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 26	0.00280899	0.1798779220740965
SANDHOFF DISEASE	0.00280899	0.1798779220740965
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00280899	0.1798779220740965
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00280899	0.1798779220740965
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00280899	0.1798779220740965
MYELOCEREBELLAR DISORDER	0.00280899	0.1798779220740965
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00280899	0.1798779220740965
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00280899	0.1798779220740965
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00280899	0.1798779220740965
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00280899	0.1798779220740965
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00280899	0.1798779220740965
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00280899	0.1798779220740965
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.00280899	0.1798779220740965
#610250 SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31	0.00280899	0.1798779220740965
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00280899	0.1798779220740965
EPISODIC ATAXIA, TYPE 8	0.00280899	0.1798779220740965
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00280899	0.1798779220740965
EPISODIC ATAXIA, TYPE 2	0.00280899	0.1798779220740965
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00280899	0.1798779220740965
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00280899	0.1798779220740965
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00280899	0.1798779220740965
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00280899	0.1798779220740965
SPINOCEREBELLAR ATAXIA 30; SCA30	0.00280899	0.1798779220740965
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.00280899	0.1798779220740965
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00280899	0.1798779220740965
OTOFACIOCERVICAL SYNDROME 2	0.00210084	0.13453046604300653
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00210084	0.13453046604300653
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00210084	0.13453046604300653
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00210084	0.13453046604300653
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00210084	0.13453046604300653
OROFACIODIGITAL SYNDROME III	0.00210084	0.13453046604300653
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00210084	0.13453046604300653
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00210084	0.13453046604300653
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00210084	0.13453046604300653
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00210084	0.13453046604300653
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00210084	0.13453046604300653
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00210084	0.13453046604300653
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00210084	0.13453046604300653
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00210084	0.13453046604300653
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00210084	0.13453046604300653
MEIER-GORLIN SYNDROME 8; MGORS8	0.00210084	0.13453046604300653
NEU-LAXOVA SYNDROME 2; NLS2	0.00210084	0.13453046604300653
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00210084	0.13453046604300653
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00210084	0.13453046604300653
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.00210084	0.13453046604300653
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00210084	0.13453046604300653
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00210084	0.13453046604300653
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00210084	0.13453046604300653
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00210084	0.13453046604300653
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.00210084	0.13453046604300653
FRONTONASAL DYSPLASIA 1; FND1	0.00210084	0.13453046604300653
BARTSOCAS-PAPAS SYNDROME; BPS	0.00210084	0.13453046604300653
HAMAMY SYNDROME; HMMS	0.00210084	0.13453046604300653
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00210084	0.13453046604300653
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.00210084	0.13453046604300653
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00210084	0.13453046604300653
DIAMOND-BLACKFAN ANEMIA 10	0.00210084	0.13453046604300653
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00210084	0.13453046604300653
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00210084	0.13453046604300653
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00210084	0.13453046604300653
FEINGOLD SYNDROME 1; FGLDS1	0.00210084	0.13453046604300653
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00210084	0.13453046604300653
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00210084	0.13453046604300653
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00210084	0.13453046604300653
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.00210084	0.13453046604300653
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00210084	0.13453046604300653
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00210084	0.13453046604300653
HYDROLETHALUS SYNDROME 1	0.00210084	0.13453046604300653
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00210084	0.13453046604300653
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00210084	0.13453046604300653
BARBER-SAY SYNDROME; BBRSAY	0.00210084	0.13453046604300653
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00210084	0.13453046604300653
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00210084	0.13453046604300653
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00210084	0.13453046604300653
FRANK-TER HAAR SYNDROME; FTHS	0.00210084	0.13453046604300653
TRISOMY 18-LIKE SYNDROME	0.00210084	0.13453046604300653
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00210084	0.13453046604300653
CEREBROOCULONASAL SYNDROME	0.00210084	0.13453046604300653
TRICHOHEPATOENTERIC SYNDROME 1	0.00210084	0.13453046604300653
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00210084	0.13453046604300653
Orofaciodigital syndrome XVII	0.00210084	0.13453046604300653
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00210084	0.13453046604300653
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00210084	0.13453046604300653
#154780 MARSHALL SYNDROME; MRSHS	0.00210084	0.13453046604300653
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00210084	0.13453046604300653
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00210084	0.13453046604300653
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00210084	0.13453046604300653
MECKEL SYNDROME, TYPE 1; MKS1	0.00210084	0.13453046604300653
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00210084	0.13453046604300653
ROBERTS SYNDROME; RBS	0.00210084	0.13453046604300653
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00210084	0.13453046604300653
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00210084	0.13453046604300653
MECKEL SYNDROME 12; MKS12	0.00210084	0.13453046604300653
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00210084	0.13453046604300653
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00210084	0.13453046604300653
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00210084	0.13453046604300653
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00210084	0.13453046604300653
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00210084	0.13453046604300653
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00210084	0.13453046604300653
OROFACIODIGITAL SYNDROME IV; OFD4	0.00210084	0.13453046604300653
KYPHOMELIC DYSPLASIA	0.00210084	0.13453046604300653
SPONDYLOOCULAR SYNDROME; SOS	0.00210084	0.13453046604300653
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00210084	0.13453046604300653
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00210084	0.13453046604300653
TRANSALDOLASE DEFICIENCY	0.00210084	0.13453046604300653
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00210084	0.13453046604300653
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00210084	0.13453046604300653
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.00210084	0.13453046604300653
SECKEL SYNDROME 4	0.00210084	0.13453046604300653
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00210084	0.13453046604300653
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00210084	0.13453046604300653
NEMALINE MYOPATHY 2; NEM2	0.00210084	0.13453046604300653
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00210084	0.13453046604300653
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00210084	0.13453046604300653
TETRAAMELIA SYNDROME 2; TETAMS2	0.00210084	0.13453046604300653
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00210084	0.13453046604300653
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00210084	0.13453046604300653
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00210084	0.13453046604300653
ACRORENAL-MANDIBULAR SYNDROME	0.00210084	0.13453046604300653
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00210084	0.13453046604300653
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00210084	0.13453046604300653
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00210084	0.13453046604300653
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00210084	0.13453046604300653
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00210084	0.13453046604300653
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00210084	0.13453046604300653
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00210084	0.13453046604300653
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00210084	0.13453046604300653
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00210084	0.13453046604300653
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00210084	0.13453046604300653
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00210084	0.13453046604300653
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00210084	0.13453046604300653
STROMME SYNDROME; STROMS	0.00210084	0.13453046604300653
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00210084	0.13453046604300653
HYPOGLOSSIA WITH SITUS INVERSUS	0.00210084	0.13453046604300653
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00210084	0.13453046604300653
NOONAN SYNDROME 8; NS8	0.00210084	0.13453046604300653
#611554 LEOPARD SYNDROME 2	0.00210084	0.13453046604300653
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00210084	0.13453046604300653
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00210084	0.13453046604300653
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00210084	0.13453046604300653
GENITOPALATOCARDIAC SYNDROME	0.00210084	0.13453046604300653
OHDO SYNDROME	0.002029341	0.12995191946563323
PSEUDO-TORCH SYNDROME 2	0.002029341	0.12995191946563323
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002029341	0.12995191946563323
GLUTARIC ACIDEMIA I; GA1	0.002029341	0.12995191946563323
MENKES DISEASE	0.002029341	0.12995191946563323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.002029341	0.12995191946563323
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.002029341	0.12995191946563323
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.002029341	0.12995191946563323
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.002029341	0.12995191946563323
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.002029341	0.12995191946563323
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002029341	0.12995191946563323
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.002029341	0.12995191946563323
SUDDEN CARDIAC FAILURE, INFANTILE	0.002029341	0.12995191946563323
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002029341	0.12995191946563323
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.002029341	0.12995191946563323
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.002029341	0.12995191946563323
VISCERAL STEATOSIS, CONGENITAL	0.002029341	0.12995191946563323
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002029341	0.12995191946563323
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002029341	0.12995191946563323
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002029341	0.12995191946563323
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.002029341	0.12995191946563323
CYCLIC VOMITING SYNDROME	0.002029341	0.12995191946563323
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.002029341	0.12995191946563323
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.002029341	0.12995191946563323
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.002029341	0.12995191946563323
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.002029341	0.12995191946563323
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002029341	0.12995191946563323
XYLOSIDASE DEFICIENCY	0.002029341	0.12995191946563323
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.002029341	0.12995191946563323
TAY-SACHS DISEASE; TSD	0.002029341	0.12995191946563323
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002029341	0.12995191946563323
MAPLE SYRUP URINE DISEASE; MSUD	0.002029341	0.12995191946563323
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002029341	0.12995191946563323
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.002029341	0.12995191946563323
MENTAL RETARDATION, X-LINKED 102	0.002029341	0.12995191946563323
NEURAMINIDASE DEFICIENCY	0.002029341	0.12995191946563323
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.002029341	0.12995191946563323
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002029341	0.12995191946563323
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.002029341	0.12995191946563323
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.002029341	0.12995191946563323
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.002029341	0.12995191946563323
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.002029341	0.12995191946563323
LISSENCEPHALY 3; LIS3	0.002029341	0.12995191946563323
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002029341	0.12995191946563323
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002029341	0.12995191946563323
GLYCINE ENCEPHALOPATHY; GCE	0.002029341	0.12995191946563323
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002029341	0.12995191946563323
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002029341	0.12995191946563323
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002029341	0.12995191946563323
ASPARTYLGLUCOSAMINURIA; AGU	0.002029341	0.12995191946563323
LISSENCEPHALY 5; LIS5	0.002029341	0.12995191946563323
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002029341	0.12995191946563323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.002029341	0.12995191946563323
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002029341	0.12995191946563323
LATHOSTEROLOSIS	0.002029341	0.12995191946563323
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.002029341	0.12995191946563323
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001957472	0.1253496793787895
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001957472	0.1253496793787895
GENITOPATELLAR SYNDROME; GTPTS	0.001957472	0.1253496793787895
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001957472	0.1253496793787895
HYPOTONIA-CYSTINURIA SYNDROME	0.001957472	0.1253496793787895
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001957472	0.1253496793787895
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001957472	0.1253496793787895
GALACTOSE EPIMERASE DEFICIENCY	0.001957472	0.1253496793787895
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001957472	0.1253496793787895
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001957472	0.1253496793787895
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001957472	0.1253496793787895
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001957472	0.1253496793787895
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001957472	0.1253496793787895
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.001957472	0.1253496793787895
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001957472	0.1253496793787895
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001957472	0.1253496793787895
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001957472	0.1253496793787895
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001957472	0.1253496793787895
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001957472	0.1253496793787895
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001957472	0.1253496793787895
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001957472	0.1253496793787895
MICROPHTHALMIA, SYNDROMIC 3	0.001957472	0.1253496793787895
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001957472	0.1253496793787895
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001957472	0.1253496793787895
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.001957472	0.1253496793787895
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001957472	0.1253496793787895
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001957472	0.1253496793787895
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001957472	0.1253496793787895
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001957472	0.1253496793787895
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001957472	0.1253496793787895
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.001957472	0.1253496793787895
MENTAL RETARDATION, X-LINKED 99	0.001957472	0.1253496793787895
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001957472	0.1253496793787895
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001957472	0.1253496793787895
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001957472	0.1253496793787895
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001957472	0.1253496793787895
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.001957472	0.1253496793787895
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.001957472	0.1253496793787895
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001957472	0.1253496793787895
ARIMA SYNDROME	0.001957472	0.1253496793787895
JOUBERT SYNDROME 26	0.001957472	0.1253496793787895
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001957472	0.1253496793787895
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001957472	0.1253496793787895
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001957472	0.1253496793787895
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001957472	0.1253496793787895
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001957472	0.1253496793787895
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001957472	0.1253496793787895
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001957472	0.1253496793787895
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001957472	0.1253496793787895
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001957472	0.1253496793787895
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001957472	0.1253496793787895
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001957472	0.1253496793787895
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001957472	0.1253496793787895
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001957472	0.1253496793787895
CHROMOSOME 4q21 DELETION SYNDROME	0.001957472	0.1253496793787895
NAVAJO NEUROHEPATOPATHY	0.001957472	0.1253496793787895
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001957472	0.1253496793787895
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001957472	0.1253496793787895
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001957472	0.1253496793787895
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.001957472	0.1253496793787895
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.001759633	0.11268075986493675
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.11268075986493675
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.11268075986493675
CITRULLINEMIA, CLASSIC	0.001759633	0.11268075986493675
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.11268075986493675
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001759633	0.11268075986493675
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.11268075986493675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.11268075986493675
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001759633	0.11268075986493675
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.11268075986493675
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.11268075986493675
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.11268075986493675
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.11268075986493675
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.11268075986493675
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001759633	0.11268075986493675
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.11268075986493675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001759633	0.11268075986493675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.11268075986493675
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001759633	0.11268075986493675
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001759633	0.11268075986493675
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.11268075986493675
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.11268075986493675
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.11268075986493675
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.11268075986493675
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.11268075986493675
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.11268075986493675
PALLISTER-HALL SYNDROME	0.001759633	0.11268075986493675
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001759633	0.11268075986493675
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.11268075986493675
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.11268075986493675
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.11268075986493675
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.11268075986493675
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.11268075986493675
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.11268075986493675
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001759633	0.11268075986493675
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001759633	0.11268075986493675
ARGININOSUCCINIC ACIDURIA	0.001759633	0.11268075986493675
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.11268075986493675
Cerebral creatine deficiency syndrome 2	0.001759633	0.11268075986493675
LISSENCEPHALY 1; LIS1	0.001759633	0.11268075986493675
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001759633	0.11268075986493675
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001759633	0.11268075986493675
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.11268075986493675
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.001759633	0.11268075986493675
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.11268075986493675
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001759633	0.11268075986493675
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.001759633	0.11268075986493675
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.11268075986493675
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.11268075986493675
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001759633	0.11268075986493675
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.001759633	0.11268075986493675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.11268075986493675
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.11268075986493675
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001759633	0.11268075986493675
LISSENCEPHALY 4	0.001759633	0.11268075986493675
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.11268075986493675
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.11268075986493675
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.001759633	0.11268075986493675
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.001759633	0.11268075986493675
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.11268075986493675
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.001759633	0.11268075986493675
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.11268075986493675
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001759633	0.11268075986493675
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.001759633	0.11268075986493675
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.11268075986493675
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001759633	0.11268075986493675
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.001759633	0.11268075986493675
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.11268075986493675
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001759633	0.11268075986493675
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.11268075986493675
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.11268075986493675
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.11268075986493675
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.11268075986493675
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001759633	0.11268075986493675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.11268075986493675
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.001759633	0.11268075986493675
OCULOECTODERMAL SYNDROME; OES	0.001759633	0.11268075986493675
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.11268075986493675
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.001759633	0.11268075986493675
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.11268075986493675
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.11268075986493675
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001759633	0.11268075986493675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.11268075986493675
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.11268075986493675
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.11268075986493675
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001759633	0.11268075986493675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.11268075986493675
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.11268075986493675
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.11268075986493675
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.11268075986493675
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.11268075986493675
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.11268075986493675
HARTNUP DISORDER	0.001759633	0.11268075986493675
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.11268075986493675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001759633	0.11268075986493675
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.11268075986493675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.11268075986493675
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.11268075986493675
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001759633	0.11268075986493675
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.11268075986493675
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.11268075986493675
MACDERMOT-WINTER SYNDROME	0.001759633	0.11268075986493675
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.11268075986493675
PHACE ASSOCIATION	0.001759633	0.11268075986493675
HOLOPROSENCEPHALY 7	0.001759633	0.11268075986493675
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.001759633	0.11268075986493675
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001759633	0.11268075986493675
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.11268075986493675
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001759633	0.11268075986493675
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.11268075986493675
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.001759633	0.11268075986493675
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.001759633	0.11268075986493675
CHROMOSOME 16p13.3 DELETION SYNDROME	0.001759633	0.11268075986493675
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.11268075986493675
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001759633	0.11268075986493675
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.11268075986493675
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.11268075986493675
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.11268075986493675
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.001759633	0.11268075986493675
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.001759633	0.11268075986493675
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.001759633	0.11268075986493675
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00111359	0.07131041948974298
MENTAL RETARDATION, X-LINKED 19	0.00111359	0.07131041948974298
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00111359	0.07131041948974298
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00111359	0.07131041948974298
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00111359	0.07131041948974298
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00111359	0.07131041948974298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00111359	0.07131041948974298
NEMALINE MYOPATHY 4	0.00111359	0.07131041948974298
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00111359	0.07131041948974298
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00111359	0.07131041948974298
OSTEOGENESIS IMPERFECTA, TYPE X	0.00111359	0.07131041948974298
MENTAL RETARDATION, X-LINKED 93	0.00111359	0.07131041948974298
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00111359	0.07131041948974298
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00111359	0.07131041948974298
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00111359	0.07131041948974298
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00111359	0.07131041948974298
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00111359	0.07131041948974298
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00111359	0.07131041948974298
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00111359	0.07131041948974298
LIVER FAILURE, INFANTILE, TRANSIENT	0.00111359	0.07131041948974298
PEROXISOME BIOGENESIS DISORDER 11B	0.00111359	0.07131041948974298
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00111359	0.07131041948974298
GLYCOGEN STORAGE DISEASE II	0.00111359	0.07131041948974298
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00111359	0.07131041948974298
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00111359	0.07131041948974298
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00111359	0.07131041948974298
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00111359	0.07131041948974298
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00111359	0.07131041948974298
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00111359	0.07131041948974298
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00111359	0.07131041948974298
SCHOLTE SYNDROME; SHLTS	0.00111359	0.07131041948974298
CHIARI MALFORMATION TYPE II	0.00111359	0.07131041948974298
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00111359	0.07131041948974298
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00111359	0.07131041948974298
ETHANOLAMINOSIS	0.00111359	0.07131041948974298
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00111359	0.07131041948974298
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00111359	0.07131041948974298
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00111359	0.07131041948974298
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00111359	0.07131041948974298
GLYCOGEN STORAGE DISEASE IV	0.00111359	0.07131041948974298
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00111359	0.07131041948974298
SENGERS SYNDROME	0.00111359	0.07131041948974298
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00111359	0.07131041948974298
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00111359	0.07131041948974298
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00111359	0.07131041948974298
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00111359	0.07131041948974298
BETHLEM MYOPATHY 2; BTHLM2	0.00111359	0.07131041948974298
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00111359	0.07131041948974298
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00111359	0.07131041948974298
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00111359	0.07131041948974298
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00111359	0.07131041948974298
PORPHYRIA, ACUTE HEPATIC	0.00111359	0.07131041948974298
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00111359	0.07131041948974298
SHPRINTZEN OMPHALOCELE SYNDROME	0.00111359	0.07131041948974298
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00111359	0.07131041948974298
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00111359	0.07131041948974298
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00111359	0.07131041948974298
HYPERCALCEMIA, INFANTILE, 1	0.00111359	0.07131041948974298
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00111359	0.07131041948974298
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00111359	0.07131041948974298
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00111359	0.07131041948974298
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00111359	0.07131041948974298
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00111359	0.07131041948974298
GLYCOGEN STORAGE DISEASE IXB	0.00111359	0.07131041948974298
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00111359	0.07131041948974298
LEGIUS SYNDROME	0.00111359	0.07131041948974298
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00111359	0.07131041948974298
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00111359	0.07131041948974298
OPSISMODYSPLASIA; OPSMD	0.00111359	0.07131041948974298
MYOTONIC DYSTROPHY 1	0.00111359	0.07131041948974298
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00111359	0.07131041948974298
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00111359	0.07131041948974298
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00111359	0.07131041948974298
EHLERS-DANLOS SYNDROME, TYPE VI	0.00111359	0.07131041948974298
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00111359	0.07131041948974298
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00111359	0.07131041948974298
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00111359	0.07131041948974298
NEMALINE MYOPATHY 7; NEM7	0.00111359	0.07131041948974298
Mulchandani-Bhoj-Conlin syndrome	0.00111359	0.07131041948974298
MYOPATHY, CENTRONUCLEAR, 5	0.00111359	0.07131041948974298
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00111359	0.07131041948974298
PIERSON SYNDROME	0.00111359	0.07131041948974298
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00111359	0.07131041948974298
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00111359	0.07131041948974298
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00111359	0.07131041948974298
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00111359	0.07131041948974298
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00111359	0.07131041948974298
OSTEOPENIA AND SPARSE HAIR	0.00111359	0.07131041948974298
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00111359	0.07131041948974298
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00111359	0.07131041948974298
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00111359	0.07131041948974298
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00111359	0.07131041948974298
WARBURG MICRO SYNDROME 1	0.00111359	0.07131041948974298
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00111359	0.07131041948974298
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00111359	0.07131041948974298
ACID PHOSPHATASE DEFICIENCY	0.00111359	0.07131041948974298
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00111359	0.07131041948974298
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00111359	0.07131041948974298
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00111359	0.07131041948974298
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00111359	0.07131041948974298
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00111359	0.07131041948974298
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00111359	0.07131041948974298
CEREBELLAR HYPOPLASIA	0.00111359	0.07131041948974298
DESBUQUOIS DYSPLASIA 1	0.00111359	0.07131041948974298
CHITAYAT SYNDROME	0.00111359	0.07131041948974298
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00111359	0.07131041948974298
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00111359	0.07131041948974298
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00111359	0.07131041948974298
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00111359	0.07131041948974298
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00111359	0.07131041948974298
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00111359	0.07131041948974298
PRIMROSE SYNDROME; PRIMS	0.00111359	0.07131041948974298
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00111359	0.07131041948974298
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00111359	0.07131041948974298
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00111359	0.07131041948974298
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00111359	0.07131041948974298
SOTOS SYNDROME 2	0.00111359	0.07131041948974298
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00111359	0.07131041948974298
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00111359	0.07131041948974298
GLYCOGEN STORAGE DISEASE IXC	0.00111359	0.07131041948974298
DYSTONIA 11, MYOCLONIC	0.00111359	0.07131041948974298
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00111359	0.07131041948974298
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.00111359	0.07131041948974298
RENPENNING SYNDROME 1; RENS1	0.000915751	0.05864149997589026
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.05864149997589026
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.05864149997589026
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.05864149997589026
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.05864149997589026
STURGE-WEBER SYNDROME	0.000915751	0.05864149997589026
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.05864149997589026
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.05864149997589026
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.05864149997589026
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.05864149997589026
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000915751	0.05864149997589026
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.05864149997589026
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.05864149997589026
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.05864149997589026
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.000915751	0.05864149997589026
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.05864149997589026
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.05864149997589026
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.05864149997589026
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.05864149997589026
GURRIERI SYNDROME	0.000915751	0.05864149997589026
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.05864149997589026
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.05864149997589026
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.05864149997589026
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.05864149997589026
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.05864149997589026
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.05864149997589026
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.05864149997589026
Angelman syndrome (Type 1)	0.000915751	0.05864149997589026
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.05864149997589026
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.05864149997589026
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.05864149997589026
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.05864149997589026
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.05864149997589026
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.05864149997589026
CLARK-BARAITSER SYNDROME	0.000915751	0.05864149997589026
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.05864149997589026
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.05864149997589026
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.05864149997589026
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.05864149997589026
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.05864149997589026
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.000915751	0.05864149997589026
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.05864149997589026
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.05864149997589026
ATKIN-FLAITZ SYNDROME	0.000915751	0.05864149997589026
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.05864149997589026
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.05864149997589026
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.000915751	0.05864149997589026
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.05864149997589026
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.05864149997589026
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.05864149997589026
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.05864149997589026
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.05864149997589026
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.05864149997589026
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.05864149997589026
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.05864149997589026
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.05864149997589026
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.05864149997589026
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.05864149997589026
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.05864149997589026
HYPERLYSINEMIA, TYPE I	0.000915751	0.05864149997589026
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.05864149997589026
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.05864149997589026
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.05864149997589026
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.05864149997589026
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.05864149997589026
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.05864149997589026
Angelman syndrome (Type 2)	0.000915751	0.05864149997589026
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.05864149997589026
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.05864149997589026
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.05864149997589026
SECKEL SYNDROME 7; SCKL7	0.000915751	0.05864149997589026
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.05864149997589026
2q33.1 deletion syndrome	0.000915751	0.05864149997589026
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.05864149997589026
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.05864149997589026
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.05864149997589026
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.000915751	0.05864149997589026
DYSOSTEOSCLEROSIS	0.000915751	0.05864149997589026
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.05864149997589026
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000915751	0.05864149997589026
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.05864149997589026
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.05864149997589026
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.05864149997589026
HYPERPROLINEMIA, TYPE II	0.000915751	0.05864149997589026
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.05864149997589026
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.05864149997589026
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.05864149997589026
ALEXANDER DISEASE	0.000915751	0.05864149997589026
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.05864149997589026
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.05864149997589026
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.05864149997589026
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.05864149997589026
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.05864149997589026
CROME SYNDROME	0.000915751	0.05864149997589026
IMMUNODEFICIENCY 47	0.000915751	0.05864149997589026
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.05864149997589026
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.05864149997589026
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.05864149997589026
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.05864149997589026
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.05864149997589026
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.05864149997589026
INCONTINENTIA PIGMENTI; IP	0.000915751	0.05864149997589026
AUTISM	0.000915751	0.05864149997589026
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.05864149997589026
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.05864149997589026
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.05864149997589026
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.05864149997589026
Wolf-Hirschhorn Syndrome	0.000915751	0.05864149997589026
HYPER-BETA-ALANINEMIA	0.000915751	0.05864149997589026
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.05864149997589026
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.05864149997589026
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.05864149997589026
KIFAFA SEIZURE DISORDER	0.000915751	0.05864149997589026
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000915751	0.05864149997589026
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.05864149997589026
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.05864149997589026
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.05864149997589026
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.05864149997589026
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.05864149997589026
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.05864149997589026
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.05864149997589026
EPILEPSY, READING	0.000915751	0.05864149997589026
1p36 microdeletion syndrome	0.000915751	0.05864149997589026
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.05864149997589026
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.05864149997589026
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.000915751	0.05864149997589026
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.05864149997589026
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.05864149997589026
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.05864149997589026
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.000915751	0.05864149997589026
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.05864149997589026
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.05864149997589026
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.05864149997589026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.05864149997589026
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.05864149997589026
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.05864149997589026
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.05864149997589026
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.05864149997589026
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.05864149997589026
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.05864149997589026
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.05864149997589026
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.05864149997589026
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.05864149997589026
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.05864149997589026
THYROCEREBRORETINAL SYNDROME	0.000915751	0.05864149997589026
DARIER-WHITE DISEASE; DAR	0.000915751	0.05864149997589026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.05864149997589026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.05864149997589026
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.05864149997589026
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.05864149997589026
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.05864149997589026
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.05864149997589026
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.05864149997589026
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.05864149997589026
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.05864149997589026
PAPILLORENAL SYNDROME	0.000915751	0.05864149997589026
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.05864149997589026
THREONINEMIA	0.000915751	0.05864149997589026
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.05864149997589026
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.05864149997589026
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.05864149997589026
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.05864149997589026
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.05864149997589026
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.05864149997589026
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.05864149997589026
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.05864149997589026
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.05864149997589026
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.05864149997589026
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.05864149997589026
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.05864149997589026
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000915751	0.05864149997589026
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.05864149997589026
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.05864149997589026
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.05864149997589026
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.05864149997589026
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.05864149997589026
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.05864149997589026
PARIETAL FORAMINA	0.000915751	0.05864149997589026
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.05864149997589026
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.05864149997589026
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.05864149997589026
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.05864149997589026
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.05864149997589026
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.05864149997589026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.05864149997589026
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.05864149997589026
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.05864149997589026
EPILEPSY-TELANGIECTASIA	0.000915751	0.05864149997589026
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.05864149997589026
DIAMINOPENTANURIA	0.000915751	0.05864149997589026
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.05864149997589026
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.05864149997589026
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.05864149997589026
RAMON SYNDROME	0.000915751	0.05864149997589026
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.05864149997589026
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.05864149997589026
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.05864149997589026
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.05864149997589026
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000915751	0.05864149997589026
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.05864149997589026
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.05864149997589026
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.05864149997589026
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.05864149997589026
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.05864149997589026
KEUTEL SYNDROME; KTLS	0.000915751	0.05864149997589026
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.05864149997589026
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.05864149997589026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.05864149997589026
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.05864149997589026
PERRAULT SYNDROME 3	0.000915751	0.05864149997589026
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.05864149997589026
KRABBE DISEASE	0.000915751	0.05864149997589026
CRANIOSYNOSTOSIS 2	0.000915751	0.05864149997589026
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.05864149997589026
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.05864149997589026
HUNTINGTON DISEASE; HD	0.000915751	0.05864149997589026
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.05864149997589026
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.05864149997589026
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.05864149997589026
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.05864149997589026
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.05864149997589026
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.05864149997589026
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.05864149997589026
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.05864149997589026
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.05864149997589026
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.05864149997589026
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.05864149997589026
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.05864149997589026
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.05864149997589026
15q13.3 microdeletion syndrome	0.000915751	0.05864149997589026
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.05864149997589026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.05864149997589026
FOUNTAIN SYNDROME	0.000915751	0.05864149997589026
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.05864149997589026
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.05864149997589026
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.05864149997589026
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.000915751	0.05864149997589026
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.05864149997589026
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.05864149997589026
CROUZON SYNDROME	0.000915751	0.05864149997589026
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.05864149997589026
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.000915751	0.05864149997589026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.05864149997589026
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.0540392598890465
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.0540392598890465
Jawad syndrome	0.000843882	0.0540392598890465
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000843882	0.0540392598890465
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.0540392598890465
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.0540392598890465
3MC SYNDROME 2	0.000843882	0.0540392598890465
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.0540392598890465
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.0540392598890465
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.0540392598890465
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.0540392598890465
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000843882	0.0540392598890465
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.0540392598890465
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.0540392598890465
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.0540392598890465
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.0540392598890465
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.0540392598890465
Cerebral creatine deficiency syndrome 3	0.000843882	0.0540392598890465
FRIAS SYNDROME	0.000843882	0.0540392598890465
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.0540392598890465
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.0540392598890465
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.0540392598890465
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.0540392598890465
CDAGS SYNDROME	0.000843882	0.0540392598890465
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.0540392598890465
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.0540392598890465
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.0540392598890465
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.0540392598890465
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.0540392598890465
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.0540392598890465
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.0540392598890465
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.0540392598890465
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.0540392598890465
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.0540392598890465
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.0540392598890465
BARATELA-SCOTT SYNDROME	0.000843882	0.0540392598890465
LIG4 SYNDROME	0.000843882	0.0540392598890465
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000843882	0.0540392598890465
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.0540392598890465
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.0540392598890465
OROTIC ACIDURIA	0.000843882	0.0540392598890465
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.0540392598890465
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.0540392598890465
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.0540392598890465
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.0540392598890465
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.0540392598890465
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.0540392598890465
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.0540392598890465
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.0540392598890465
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.0540392598890465
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.0540392598890465
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.0540392598890465
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000843882	0.0540392598890465
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.0540392598890465
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.0540392598890465
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000843882	0.0540392598890465
SENIOR-LOKEN SYNDROME 9	0.000843882	0.0540392598890465
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.0540392598890465
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.0540392598890465
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000843882	0.0540392598890465
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.0540392598890465
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.0540392598890465
SECKEL SYNDROME 9; SCKL9	0.000843882	0.0540392598890465
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.0540392598890465
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.0540392598890465
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.0540392598890465
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.0540392598890465
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000843882	0.0540392598890465
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.0540392598890465
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.0540392598890465
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.0540392598890465
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000843882	0.0540392598890465
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.0540392598890465
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.0540392598890465
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.0540392598890465
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.0540392598890465
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.0540392598890465
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.0540392598890465
AUSTRALIA ANTIGEN	0.000843882	0.0540392598890465
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.0540392598890465
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.0540392598890465
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.0540392598890465
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.0540392598890465
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.0540392598890465
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.0540392598890465
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.0540392598890465
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.0540392598890465
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.0540392598890465
EVEN-PLUS SYNDROME	0.000843882	0.0540392598890465
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.0540392598890465
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.0540392598890465
HOLOPROSENCEPHALY 11	0.000843882	0.0540392598890465
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.0540392598890465
SECKEL SYNDROME 8; SCKL8	0.000843882	0.0540392598890465
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.0540392598890465
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.0540392598890465
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.0540392598890465
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.0540392598890465
REVESZ SYNDROME	0.000843882	0.0540392598890465
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.0540392598890465
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.0540392598890465
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.0540392598890465
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.0540392598890465
NOONAN SYNDROME 9; NS9	0.000843882	0.0540392598890465
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.0540392598890465
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.0540392598890465
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.0540392598890465
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.0540392598890465
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.0540392598890465
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.0540392598890465
LOWRY-MACLEAN SYNDROME	0.000843882	0.0540392598890465
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.0540392598890465
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.0540392598890465
Bardet-Biedl syndrome 2	0.000843882	0.0540392598890465
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.0540392598890465
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.0540392598890465
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.0540392598890465
CURRARINO SYNDROME	0.000843882	0.0540392598890465
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000843882	0.0540392598890465
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.0540392598890465
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000843882	0.0540392598890465
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.0540392598890465
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.0540392598890465
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.0540392598890465
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.0540392598890465
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.0540392598890465
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.0540392598890465
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.0540392598890465
RAHMAN SYNDROME	0.000843882	0.0540392598890465
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.0540392598890465
CULLER-JONES SYNDROME; CJS	0.000843882	0.0540392598890465
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.0540392598890465
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.0540392598890465
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.0540392598890465
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.0540392598890465
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.0540392598890465
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.0540392598890465
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.0540392598890465
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.0540392598890465
MEIER-GORLIN SYNDROME 7	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.0540392598890465
Leukotriene C4 synthase deficiency	0.000843882	0.0540392598890465
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000843882	0.0540392598890465
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.0540392598890465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.0540392598890465
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.0540392598890465
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.0540392598890465
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.0540392598890465
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.0540392598890465
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.0540392598890465
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.0540392598890465
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000843882	0.0540392598890465
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.0540392598890465
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.0540392598890465
WAARDENBURG-SHAH SYNDROME	0.000843882	0.0540392598890465
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.0540392598890465
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.0540392598890465
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.0540392598890465
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.0540392598890465
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.0540392598890465
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.0540392598890465
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.0540392598890465
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.0540392598890465
SEPTOOPTIC DYSPLASIA	0.000843882	0.0540392598890465
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.0540392598890465
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.0540392598890465
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.0540392598890465
SILVER-RUSSELL SYNDROME; SRS	0.000843882	0.0540392598890465
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.0540392598890465
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.0540392598890465
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.0540392598890465
#170100 PROLIDASE DEFICIENCY	0.000843882	0.0540392598890465
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.0540392598890465
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.0540392598890465
NOONAN SYNDROME 2; NS2	0.000843882	0.0540392598890465
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.0540392598890465
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.0540392598890465
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.0540392598890465
STEEL SYNDROME; STLS	0.000843882	0.0540392598890465
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.0540392598890465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.000843882	0.0540392598890465
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.0540392598890465
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.000843882	0.0540392598890465
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.0540392598890465
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.0540392598890465
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.0540392598890465
